Warning

“Queensland Statute Reprints” QUT Digital Collections

This copy is not an authorised reprint within the meaning of the Reprints Act 1992 (Qld). This digitized copy of a Queensland legislation pamphlet reprint is made available for non-commercial educational and research purposes only. It may not be reproduced for commercial gain.

©State of Queensland

QUEENSLAND

AMENDMENTS OF THE POISONS REGULATIONS OF 1973

Published in Queensland Government Gazette, dated 2nd March, 1985, Vol. CCLXXVIII, No. 47, pages 1045-1127

66278-By Authority: S. R. HAMPSON, Government Printer, Queensland Health Act 1937-1984 AMENDMENTS OF REGULATIONS

Department of Health Brisbane, 28th February, 1985 HIS Excellency the Governor, acting by and with the advice of the Executive Council and in pursuance of the provisions of the Health Act 1937-1984, has been pleased to approve of the following Regulations made by the Director-General of Health and Medical Services for the State of Queensland. BRIAN AUSTIN

AMENDMENTS OF "THE POISONS REGULATIONS OF 1973" WHEREAS, by the Health Act 1937-1984, it is amongst other things enacted that the Director-General may make regulations: Now, therefore the Director-General, with the approval of His Excellency the Governor with the advice of the Executive Council, doth hereby make the following Regulations:- !. "The Poisons Regulations of 1973" as previously amended are in these Regulations referred to as the Principal Regulations. 2. Subregulation A2.07 of the Principal Regulations is amended by inserting after Clause (n) the following Clause- (o) Single-use tubes for the estimation of the alcohol content of breath. 3. The Principal Regulations are amended by repealing Regulation AS and substituting the following Regulation- AS. Prohibited Drugs and Poisons. AS.Ol. A person shall not have in his possession, prescribe, dispense, sell, lend, give away, supply nor use any of the following substances unless that person is engaged upon medical or scientific research or analyses and has received the written approval of the Director-General in that regard:- Acetorphine Ally lisopropy lacety1 urea Amidopyrine and its derivatives for human therapeutic use Amygdalin Arprinocid Bithionol for human therapeutic use Buclosamide 2 Amendments-The Poisons Regulations of 1973

Buniodyl sodium Calamus for human therapeutic use Cannabis (Indian hemp) and cannabis resin and extracts and tinctures of cannabis Clioquinol and other halogenated 8-hydroxyquinoline derivatives for internal human use Desomorphine Dienochlor Dulcin Etorphine Flunixin Meglumine for human therapeutic use Ivermectin Ketobemidone Methapyrilene Methfuroxam Methyl Cincophen (methyl ester of phenylcinchoninic acid) Nitro fen Oxyphenisatin for human therapeutic use Sulfallate Tetrahydrocannabinols Thalidomide 1,1,1-trichloroethane in aerosols for therapeutic use Triparanol or a preparation containing any proportion whatsoever of any of the substances listed in this subregulation. 4. Subregulation A6.0 1 of the Principal Regulations is amended by in clause (c)- (i) inserting immediately after the entry "N, N-Dimethyltryptamine" the following entry- "N-Ethyl-1- Phencyclohexylamine (PCE)" (ii) inserting immediately after the entry "Parahexyl" the following entry- "1-(1-Phenylcyclohexyl) Pyrrolidine (PHP or PCPY)" 5. Subregulation A 7.06 of the Principal Regulations is amended by in clause (f) omitting the word "dispensing" and substituting the word "supply". 6. The Principal Regulations are amended by omitting subregulation A7.08 and substituting the following subregulation- A7.08. A school dental therapist who is performing prescribed duties under and within the meaning of the Dental Act 1971-1973 may, subject Amendments-The Poisons Regulations of 1973 3 to these Regulations, use such of those poisons contained in Schedule 2 to these Regulations as are specified hereunder:-

SCHEDULE 2 Ether and substances containing more than 10 per cent of ether except when included in Schedule 4, Schedule 5 or Schedule 6. Auorides- (a) Sodium fluoride in substances for human ingestion containing 2.2 mg or less of sodium fluoride per dosage unit; and (b) other metallic fluoride substances including ammonium fluoride for therapeutic use except- (i) in dentifrices containing 1 000 mgjkg or less of fluoride ion; or (ii) in substances containing 15 mgjkg or less of fluoride ion. Lignocaine when included in substances for external use, other than eyedrops, containing ten per cent or less of lignocaine. Mercury, metallic (excluding its salts) except in scientific instruments. Phenol and any homologue of phenol boiling below 220°C, creosote and substances containing more than 3 per cent of such substances or homologues, for therapeutic use. 7. The Principal Regulations are amended by inserting after subregulation A7.08 the following subregulation- A7.09. The Director-General may authorise in writing the obtaining, possession, sale, supply or use of a Schedule 3 poison by a person under the conditions set out in such authority. 8. Subregulation A8.01 of the Principal Regulations is amended by omitting the expression "Schedules 6 or 7" and substituting the expression "Appendix A to Schedule 6, or Schedule 7". 9. Subregulation Bl.Ol of the Principal Regulations is amended by in clause (c) inserting the word "securely" immediately after the word "being". 10. The Principal Regulations are amended by omitting subregulation B1.03 and substituting the following subregulation- Bl.03. A dangerous drug, restricted drug or poison, other than a poison specified in Schedule 5, shall not be sold in a bottle or jar having a capacity of more than two litres, or in any other immediate container unless- (a) the word "Poison" is embossed on the side of such bottle, jar or other immediate container in letters of a height not less than one thirty-second part of the depth of such bottle, jar or other immediate container; (b) the word "Poison" is indelibly written on the. side of such, bottle, jar or other immediate container in a contrasting 4 Amendments-The Poisons Regulations of 1973

colour to the background colour and in letters of a height not less than one thirty-second part of the depth of such bottle, jar or other immediate container; or (c) such bottle, jar or other immediate container is labelled so that- (i) the label is indelibly printed directly onto such bottle, jar or other immediate container; or (ii) in the case of a fibreboard container the label cannot be removed without damage to the container or label. 11. The Principal Regulations are amended by omitting subregulation Bl.07 and substituting the following subregulation- B1.07. (a) A poison specified in Schedule 5 shall not be sold in an immediate container unless such immediate container- (i) is readily distinguishable from a container in which food or drink is sold; and (ii)- (1) has embossed or indelibly written thereon the word "Poison" or the words "Not to be taken" or the words "Not to be used as a food container"; (2) the label is indelibly printed directly on the such immediate container; or (3) in the case of a fibreboard container the label cannot be removed without damage to such container or label. (b) The following poisons specified in Schedule 5, namely­ Methylated Spirit, Kerosene, Mineral Turpentine, Petrol, White Spirit and any other liquid hydrocarbon shall not be sold in a bottle or jar having a capacity of two litres or less unless- (i) the outer surface of such bottle or jar has embossed thereon prominent vertical ribs or grooves or prominent points or stars of sufficient number to render the bottle or jar distinguishable by sight and by touch from bottles or jars ordinarily used as containers for any food, drink, condiment or medicine for internal use; (ii) such bottle or jar if made of glass is coloured brown; and (iii) such bottle or jar complies with the provisions of clause (a) of this subregulation. 12. the Principal Regulations are amended by­ (i) renumbering subregulation Bl.08 as Bl.09; (ii) inserting the following subregulation immediately after subregulation B 1.07. Amendments-The Poisons Regulations of 1973 5

Bl.OS. A poison specified in the following Table shall not be sold in a bottle, jar or can having a capacity as specified in the Table unless such bottle, jar or can is fitted with a closure of a type approved by the Director-General. THE TABLE

Poison Capacity

Hydrocarbons, liquids specified in Schedule 5, the following only Kerosene, mineral turpentine, dry cleaning fluid 5 litres or less

Methylated spirit specified .in Schedule 5 5 litres or less

Hydrochloric acid in aqueous substances specified in Schedule 6 2.5 litres or less

Sodium hydroxide specified in Schedule 6 2.5 litres or less

13. Subregulation B6.01 of the Principal Regulations is amended by inserting the words "drug or" after the word "any". 14. Subregulation Cl.02 of the Principal Regulations is amended by omitting clause (c) and substituting the following clause- "(c) a poison specified in Schedule 7 unless it is stored in a receptacle or storeroom under lock and key or in a secure place to the satisfaction of the Director-General. The key of such receptacle or storeroom shall remain at all times in the possession of such person or of a responsible person delegated by him. 15. The Principal Regulations are amended by inserting after subregulation C3.07 the following subregulation- "C3.08. The Director-General may in his discretion, suspend or cancel a permit granted by him under this Regulation". 16. The Principal Regulations are amended by repealing Regulation C8 and substituting the following Regulation- "CS. Sale and use of strychnine. CS.Ol. For the purpose of this Regulation strychnine is the poison specified in Schedule 7 as- "Strychnine except when included in Schedule 4". C8.02. A person shall not be in possession of nor use strychnine unless he is- (a) a person so authorised by these Regulations; or 6 Amendments-The Poisons Regulations of 1973

(b) the holder of a permit in Form Bl of Schedule 9 to these · Regulations. C8.03. A person desiring to obtain strychnine shall make application to the Director-General in Form B of Schedule 9 to these Regulations. C8.04. The Director-General may, at his discretion, issue to the applicant a permit in Form B 1 of Schedule 9 to these Regulations. CS.OS. The holder of a permit which has been issued under this Regulation shall not:- (a) use such strychnine for any purpose other than that stated in the permit; (b) store such strychnine at a place other than that stated in the permit; and (c) have any strychnine in his possession after the expiration of the time stated in the permit. C8.06. A person shall not sell strychnine unless the intending purchaser produces a permit in Form Bl: Provided that this prohibition shall not apply to a bona fide wholesale sale by a licensed wholesale seller of poisons to a pharmacist or to another licensed seller of poisons. C8.07. A person who has obtained strychnine as the holder of a permit shall keep such strychnine under lock and key in a secure place. The key of such secure place shall remain at all times in the possession of the holder of the permit or of a responsible person delegated by such permit holder. CS.OS. The permit holder or the responsible person delegated by him shall not at any time leave such strychnine as to be accessible to others. C8.09. A person who has strychnine in his possession at the time this Regulation comes into force shall within the period of three months thereafter notify the Director-General to that effect and make application for a permit to be in possession of and for the use of such strychnine in accordance with the provisions of this Regulation. CS.lO. A person who buys strychnine outside the State shall immediately such strychnine comes into his possession at any place within the State, notify the Director-General to that effect and make application for a permit to be in possession of and for the use of such strychnine in accordance with the provisions of this Regulation. CS.ll. The Director-General may in his discretion suspend or cancel a permit granted by him under this Regulation. Amendments-The Poisons Regulations of 1973 7

17. The Principal Regulations are amended by omitting subregulation D2.04 and substituting the following subregulation- D2.04. A dentist engaged in carrying on the practice of dentistry is hereby authorised only to the extent necessary for the practice of his profession and subject to the provisions of these Regulations- (a) to buy, obtain and administer in the treatment ofhis patients at the time of surgery the following dangerous drugs:- Pethidine Papavetetum Codeine Morphine Oxycodone Pentazocine; (b) to have in his possession upon the premises or place occupied by him for the purpose of the practice of dentistry the dangerous drugs referred to in clause (a) of this subregulation; (c) to prescribe for the purpose of dental treatment of a person whom he is treating in the course of his practice of dentistry the dangerous drugs codeine and pentazocine provided the quantity prescribed does not exceed three days' supply; (d) to buy, obtain and administer in the treatment of his patients and to have in his possession upon the premises or place occupied by him for the purpose of his practice of dentistry a restricted drug; and (e) to prescribe for the purposes of dental treatment of a person who he is treating in the course of his practice of dentistry a restricted drug. 18. Subregulation D2.16 of the Principal Regulations is amended by omitting the words "Anaesthetics, local, being synthetic cocaine substitutes except when included in Schedule 3, lignocaine and prilocaine only" and substituting the following words- "Lignocaine except when included in Schedule 2, Prilocaine". 19. The Principal Regulations are amended by omitting subregulation D2.17 and substituting the following subregulation- D2.17. An ambulance officer employed by a Queensland Ambulance Transport Brigade Committee and who has successfully completed a course at the Queensland Ambulance Transport Brigade Training School approved by the Director-General is hereby authorised to obtain, have in his possession and use the following restricted drug but only to the extent that such drug is required for the due performance of his duties. Salbutamol except when included in Schedule 3. 8 Amendments-The Poisons Regulations of 1973

20. Subregulation G 1.03 of the Principal Regulations is amended by inserting after clause (i) the following clause- (j) For the sale or supply of a restricted drug to a chiropodist authorised under subregulation D2.19 such written order shall be endorsed "Regulation D2.19" and shall be signed by such chiropodsist with his usual signature. 21. Subregulation 11.01 of the Principal Regulations is amended by in clause (a) inserting the words "in ink" after the word "therein". 22. Subregulation Jl.02 of the Principal Regulations is amended by in clause (b) inserting the words "or his delegate" after the word "subregulation". 23. The Principal Regulations are amended by inserting after subregulation J3.03 the following subregulation- "J3.04. All entries required by this Regulation shall be recorded in ink on the day of the transaction." 24. The Principal Regulations are amended by repealing Regulation 05 and substituting the following Regulation- 0.5 Colouring of Certain Drugs and Poisons. 05.01. A person shall not sell nor use an antibiotic substance packed in an applicator device specially designed for intramammary infusion in animals unless and until such antibiotic substance is suitably coloured with Brilliant Blue FCF or other approved colour as a marker. 05.02. A person shall not sell nor use, for the purpose of pest destruction, a cereal, grain or meal containing a poison unless and until such cereal, grain or meal is coloured in a manner approved by the Director-General. 25. Subregulation 010.01 of the Principal Regulations is amended by omitting clause (b) and substituting the following clause- (b) The provisions of this subregulation shall not apply to­ (1) the laying of baits for the purposes of pest destruction; (2) the application of herbicides for the destruction of noxious weeds or unwanted vegetation; (3) the application of insecticides to a water course, creek, river, dam, or other collection of water for the destruction or control of mosquitoes; or (4) the application of insecticides to the land surrounding a watercourse, creek, river, dam, or other collection of water for the destruction or control of midges by a person- (i) acting under a permit or authority of the Director-General or of a Local Authority; (ii) acting in pursuance of the provision of the Stock Routes and Rural Lands Protection Act, 1944-1984; or Amendments-The Poisons Regulations of 1973 9

(iii) acting on behalf of a Cane Pest and Disease Control Board in pursuance of the provisions of the Sugar Experiment Stations Act 1900-1983. 26. The Principal Regulations are amended by omitting Schedules 1 to 8 inclusive (together with any Appendices) and substituting the following Schedules- 10 Amendments-The Poisons Regulations of 1973 SCHEDULE 1 POISONS Aconite (Root of aconitum napellus). Antimony, compounds of except:- (a) antimony chlorides in polishes; or (b) when included in Schedule 4. Atropine except when included in Schedule 2 or Schedule 4. Belladonna and substances containing more than 0.25 per cent. of the alkaloids of belladonna calculated as hyoscyamine. Bromine (excluding its salts). Brucine except when, used in concentrations of 0.02 per cent. or less for the denaturation of alcohol. Comfrey (symphytum) being preparations and admixtures for internal use of comminuted leaves or dried and powdered root or any part of the dried plant. Coniine. Cotarnine. Croton Oil. Homatropine and substances containing more than 0.25 per cent. of homatropine. Hydrocyanic acid and cyanides for therapeutic use in substances con­ taining more than the equivalent of 0.15 per cent. of hydrocyanic acid. Hyoscine except when included in Schedule 2 or Schedule 4. Hyoscyamine and substances containing more than 0.25 per cent. of hyoscyamine. Hyoscyamus and substances containing more than 0.25 per cent. of the alkaloids calculated as hyoscyamine. Lobelia and substances containing; more than 0.5 per cent. of the alkaloids except preparations for smoking or burning. Mercuric chloride except:- (a) in substances containing 0.5 per cent. or less of mercuric chloride; or (b) in batteries; or (c) when included in Schedule 7. Mercuric iodide except when included in Schedule 2 or Schequle 6. Mercuric nitrate and substances containing more than the equivalent of 3 per cent. of mercury (Hg), in such form. Mercuric-potassium iodide and substances containing more than the equivalent of 2 per cent. of mercuric iodide in such form. Mercuric thiocyanate except when included in Schedule 6. Mercury, organic compounds of, except:- (a) when included in Schedule 2, Schedule 4 or Schedule 6; or Amendments-The Poisons Regulations of 1973 11

(b) ethoxyethylmercury chloride and ethylmercury chloride in Schedule 7; or (c) in substances containing 0.01 per cent or less of mercury as a preservative. Nux vomica. Phosphorus, yellow (excluding its salts) except when included in Sched­ ule 6 or Schedule 7. Savin, oil of. Stramonium and substances containing more than 0.25 per cent. of the alkaloids calculated as hyoscyamine except preparations for smok­ ing or burning. Tansy, oil of. Veratrum except for therapeutic use. 12 Amendments-The Poisons Regulations of 1973

SCHEDULE 2 POISONS Acetic Acid (excluding its salts) and substances containing more than 80 per cent. of acetic acid, for therapeutic use. Acetyldihydrocodeine in compounded preparations containing 1 per cent. or less of acetyldihydrocodeine. Antazoline- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Aspirin, whether or not compounded or combined with another sub­ stance, for internal use except where- (a) included in Schedule 4; or (b) not compounded or combined with a therapeutically active substance and- (i) in the form of a tablet or capsule containing not more than 325 milligrams of aspirin with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or (ii) in the form of a powder containing not more than 650 milligrams of aspirin each powder being packed in an immediate wrapper with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 650 milligrams of aspirin with not more than 12 immediate wrappers in each such container or in a primary pack. Atropine, except when included in Schedule 4, (a) in substances containing 0.25 per cent. or less of atropine; and (b) atropine sulphate, 0.6 mg tablets in packs of six, when labelled for treatment of organophosphorus poisoning. Bamipine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Belladonna in substances containing 0.25 per cent. or less of the alkaloids of belladonna, calculated as hyoscyamine. Benzamine ·when included in- (i) lozenges, pastilles, tablets or capsules containing 30mg or less of benzamine in each; or Amendments-The Poisons Regulations of 1973 13

(ii) suppositories or bougies containing 200mg or less of ben­ zamine in each; or (iii) substances for external use, other than eye drops, containing 10 per cent. or less of benzamine. Benzocaine when included in- (i) lozenges, pastilles, tablets or capsules containing 30mg or less of benzocaine in each; or (ii) suppositories or bougies containing 200 mg or less of ben­ zocaine in each; or (iii) substances for external use, other than eye drops, containing 10 per cent. or less of benzocaine. Benzoyl peroxide in substances for external human therapeutic use containing 5 per cent. or less of benzoyl peroxide. Bromhexine. Bromodiphenhydramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Brompheniramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Buclizine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Bufexamac- (i) in substances containing 5 per cent. or less of bufexamac for external human therapeutic use; or (ii) in suppositories. Butylaminobenzoate when included in- (i) lozenges, pastilles, tablets or capsules containing 30 mg or less of butylaminobenzoate in each; or (ii) suppositories or bougies containing 200 mg or less of buty­ laminobenzoate in each; or (iii) substances for external use, other than eye drops, containing 10 per cent. or less of butylaminobenzoate. Carbaryl in substances for external human therapeutic use containing· 2 per cent. or less of carbaryl. 14 Amendments-The Poisons Regulations of 1973

Carbenoxolone for topical oral use. Carbetapentane except in substances containing 0.5 per cent. or less of carbetapentane. Carbinoxamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Chloroform (excluding its derivatives) except- (a) in substances containing 10 per cent. or less of chloroform where the chloroform content is declared on the label; or (b) when included in Schedule 4. Chloropyrilene- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Chlorpheniramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Chlorphenoxamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Cinnamedrine. Cinnarizine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Clemastine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Clemizole- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or Amendments-The Poisons Regulations of 1973 15

(ii) in oral substances labelled and packed for the relief of coughs and colds. Clioquinol, and other halogenated derivatives of 8-hydroxy-quinoline for external human use. Codeine- (i) Subject to paragraph (ii), where compounded or combined in a preparation containing- (a) not more than 10 mg of codeine per dosage unit when in divided preparations; or (b) not more than 0. 5 per cent. of codeine when in undivided preparations; (ii) where compounded or combined with either aspirin or paracetamol or salicylamide in tablets, capsules or powders containing not more than 10 mg of codeine per tablet, capsule or powder whether with or without a substance or quantity of substance not included in a Schedule, and (a) with not more than 25 tablets or capsules in a primary pack; or (b) with not more than 12 powders in each such pack or container or in a primary pack. Cycliramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Cyproheptadine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Deptropine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Dexbrompheniramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of co:ughs and colds. Dexchlorpheniramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or 16 Amendments-The Poisons Regulations of 1973

(ii) in oral substances labelled and packed for the relief of coughs and colds. Dextromethorphan in compounded preparations containing 1 per cent. or less of dextromethorphan. Dextrorphan in substances containing 1 per cent. or less of dextrorphan. Diamines, phenylene, toluene and all other alkylated benzene diamine derivatives, except when included in Schedule 6. Dicophane (DDT) in substances for human therapeutic use. Dicyclomine in substances containing 0.1 per cent. or less of dicyclomine. Dihydrocodeine in compounded preparations containing 1 per cent. or less of dihydrocodeine. Dimenhydrinate- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Dimethindene- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Dimethisoquin in substances for topical use. Dimethothiazine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Diphemanil methylsulphate in substances for topical use. Diphenhydramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Diphenylpyraline- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Amendments-The Poisons Regulations of 1973 17

Doxylamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. · Embramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Ephedrine- (i) in compounded preparations containing more than 10 mg of ephedrine per doseage unit; or (ii) in substances for external use containing more than 1 per cent. of ephedrine. Erythrityl tetranitrate and other nitric esters of polyhydric alcohols. Etafedrine. Ether and substances containing more than 10 per cent. of ether except when included in Schedule 4, Schedule 5 or Schedule 6. Ethoheptazine in substances containing 1 per cent. or less of ethoheptazine. Ethylmorphine in compounded preparations containing 1 per cent. or less of ethylmorphine. Ferrous sulphate and other iron preparations for human internal use, except in substances containing 5 per cent. or less of iron. Fluorides- (i) Sodium fluoride in substances for human ingestion contain­ ing 2.2 mg or less of sodium fluoride per dosage unit; and (ii) other metallic fluoride substances including ammonium fluoride for therapeutic use except- (a) in dentrifices containing 1000 mg/kg or less of fluoride ion; or (b) in substances containing 15 mgjkg or less of fluoride ion. Gelsemium. Glyceryl trinitrate except when included in Schedule 4. Guaiphenesin- (i) in liquid substances containing 2 per cent. or less of guai­ phenesin; or (ii) in solid dose substances containing 120 mg or less of guai­ phenesin in each dosage unit. Halopyramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or 18 Amendments-The Poisons Regulations of 1973

(ii) in oral substances labelled and packed for the relief of coughs and colds. Hexachlorophane in substances for skin cleansing purposes containing 3 per cent. or less of hexachlorophane except- (a) in substances for use on infants; or (b) in substances for veterinary use. Histapyrrodine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Homatropine in substances containing 0.25 per cent. or less of homatropine. Human chorionic gonadotrophin in pregnancy test kits. Hydrocyanic acid and cyanides in substances containing the equivalent of 0.15 per cent. or less of hydrocyanic acid. &-Hydroxyquinoline and its non-halogenated derivatives for human therapeutic use except in substances for external use containing one per cent or less of such substances. Hyoscine, except when included in Schedule 4, in substances containing 0.25 per cent. or less of hyoscine. Hyoscyamine in substances containing 0.25 per cent. or less hyoscyamine. Hyoscyamus in substances containing 0.25 per cent. or less of the alkaloids calculated as hyoscyamine. Iodine (excluding its salts, derivatives and iodophors) in substances for human therapeutic use containing more than 2.5 per cent. of available iodine. Isopropamide in substances containing 2 per cent. or less of isopropam- ide for cutaneous use. Isosorbide dinitrate. Lead compounds for human therapeutic use. Lignocaine when included in- (i) lozenges, pastilles, tablets or capsules containing 30 mg or less of lignocaine in each; or (ii) suppositories or bougies containing 200 mg or less of lig­ nocaine in each; or (iii) substances for external use, other than eye drops, containing 10 per cent. or less of lignocaine. Lindane in substances for external human therapeutic use containing two per cent. or less of lindane. Lobelia in substances containing 0.5 per cent. or less of the alkaloids of lobelia, except preparations for smoking or burning. Maldison in substances for external human therapeutic use containing 2 per cent. or less of maldison. Amendments-The Poisons Regulations of 1973 19 Mebendazole for human therapeutic use. Mepyramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Mercuric ammonium chloride (ammoniated mercury). Mercuric chloride in substances containing 0.5 per cent. or less of mercuric chloride, except- (a) in batteries; or (b) when included in Schedule 7. Mercuric iodide in substances for therapeutic use containing 2 per cent. or less of mercuric iodide. Mercuric nitrate in substances containing the equivalent of 3 per cent. or less of mercury (Hg), in such form. Mercuric oxide and all oxides of mercury. Mercuric potassium iodide in substances containing the equivalent of 2 per cent. or less of mercuric iodide, in such form. Mercury, metallic (excluding its salts), except in scientific instruments. Mercury, organic compounds of, for topical therapeutic use in substances containing 0.5 per cent. or less of mercury. Methdilazine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Methoxamine except- (a) substances containing 0.5 per cent. or less of methoxamine; or (b) substances for external use containing 1 per cent. or less of methoxamine. Methoxyphenamine. Methylephedrine. Naphazoline. Niclosamide for human therapeutic use. Nicocodine in compounded preparations containing 1 per cent. or less of nicocodine. Nicodicodine in compounded preparations containing 1 per cent. or less of nicodicodine. Norcodeine in compounded preparations containing 1 per cent. or less of norcodeine. Noscapine. Octyl nitrite. 20 Amendments-The Poisons Regulations of 1973

Oxethazaine in substances for internal use only. Oxolamine. Oxymetazoline. Papaverine. Paracetamol, whether or not compounded or combined with another substance, for internal use except where- (a) included in Schedule 4; or (b) not compounded or combined with a therapeutically active substance and- (i) in the form of a tablet or capsule containing not more than 500 milligrams of paracetamol with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or (ii) in the form of a powder containing not more than 1000 milligrams of paracetamol each powder being packed in an immediate wrapper with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 1000 milligrams of paracetamol with not more than 12 immediate wrappers in each such container or in a primary pack. Phedrazine. Phenamazoline. Phenazone for external use. Phenindamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Pheniramine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Phenol and any homologue of phenol boiling below 220°C, creosote, and substances containing more than 3 per cent. of such substances or homologues, for therapeutic use. Phenylephrine except- (a) substances containing 0.5 per cent. or less of phenylephrine; or (b) substances for external use containing 1 per cent. or less of phenylephrine. Amendments-The Poisons Regulations of 1973 21

Phenyltoloxamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Pholcodine in compounded preparations containing 1 per cent. :or less of pholcodine. Podophyllum Resin (Podophyllin) for external human use in substances containing 10 per cent. of less or podophyllin. Potassium chlorate and substances containing more than 10 per cent. of potassium chlorate. Pramoxine when included in substances for external use, other than eye drops, containing 1 per cent. or less of pramoxine. Procyclidine in substances containing 5 per cent. or less of procyclidine for cutaneous use. Promethazine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (iii) in oral substances labelled and packed for the relief of coughs and colds. Propantheline in substances for topical use. Propoxur in substances for external human therapeutic use containing 0.2 per cent. or less of propoxur. Propylhexedrine in appliances for inhalation in which the substance is absorbed upon an inert solid material. Propyphenazone. Pseudoephedrine except- (a) substances containing 20 mg or less of pseudoephedrine per dosage unit; or (b) substances for external use containing 1 per cent. or less of pseudoephedrine. Pyrantel for human therapeutic use. Pyrrobutamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Salicylamide, whether or not compounded or combined with another substance, for internal use except where- (a) included in Schedule 4; or 22 Amendments-The Poisons Regulations of 197 3

(b) not compounded or combined with a therapeutically active substance and- (i) in the form of a tablet or capsule containing not more than 500 milligrams of salicylamide with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or (ii) in the form of a powder containing not more than 1 000 milligrams of salicylamide each powder being packed in an immediate wrapper with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 1 000 milligrams of salicylamide with not more than 12 immediate wrappers in each such container or,, in a primary pack. Silver nitrate. Sodium nitrite for therapeutic use. Staphisagria except in substances containing 0.2 per cent. or less of staphisagria. Stramonium in substances containing 0.25 per cent. or less of the alkaloids calculated as hyoscyamine, except preparations for smok­ ing or burning. Tetrahydrozoline. Thenalidine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Thenyldiamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Tolpropamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Tramazoline. Trimeprazine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Amendments-The Poisons Regulations of 1973 23

Trimethobenzamide- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Trimizoline. Tripelannamine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Triprolidine- (i) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (ii) in oral substances labelled and packed for the relief of coughs and colds. Tymazoline. Xylometazoline. Zinc pyrithione except when included in Schedule 5. 24 Amendments-The Poisons Regulations of 1973

SCHEDULE 3 POISONS Acepifylline in oral liquid substances. Adrenaline, natural or synthetic, in substances containing more than 0.01 per cent. but not more than 1 per cent. of adrenaline. Aminophylline in oral liquid substances. Amyl nitrite. Antazoline in oral substances except when included in Schedule 2. Bamipine in oral substances except when included in Schedule 2. Benzoyl peroxide in substances for external human therapeutic use containing 10 :Per cent. or less of benzoyl peroxide except when included in Schedule 2. Bromodiphenhydramine in oral substances except when included in Schedule 2. Brompheniramine in oral substances except when included in Schedule 2. Buclizine in oral substances except when included in Schedule 2. Butyl nitrite. Carbinoxamine in oral substances except when included in Schedule 2. Chloropyrilene in oral substances except when included in Schedule 2. Chlorpheniramine in oral substances except when included in Schedule 2. Chlorphenoxamine in oral substances except when included in Schedule 2. Cinnarizine in oral substances except when included in Schedule 2. Clemastine in oral substances except when included in Schedule 2. Clemizole in oral substances except when included in Schedule 2. Codeine where compounded or combined with either aspirin or para- cetamol or salicylamide in tablets or capsules containing not more than 10 mg of codeine per tablet or capsule except when included in Schedule 2. Cycliramine in oral substances except when included in Schedule 2. Cyproheptadine in oral substances except when included in Schedule 2. Deptropine in oral substances except when included in Schedule 2. Dexbrompheniramine in oral substances except when included in Sched­ ule 2. Dexchlorpheniramine in oral substances except when included in Sched­ ule 2. Dimenhydrinate in oral substances except when included in Schedule 2. Dimethindene in oral substances except when included in Schedule 2. Amendments-The Poisons Regulations of 1973 25

Dimethothiazine in oral substances except when included in Schedule 2. Diphenhydramine in oral substances except when included in Schedule 2. Diphenylpyraline in oral substances except when included in Schedule 2. Dithranol for human therapeutic use. Doxylamine in oral substances except when included in Schedule 2. Econazole for human use in preparations containing 1 per cent or less of econazole for treatment of fungal infections of the skin. Embramine in oral substances except when included in Schedule 2. Ephedrine except- (a) substances containing 10 mg or less of ephedrine per dosage unit; or (b) substances for external use containing 1 per cent or less of ephedrine; or (c) when included in Schedule 2. Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose. Flavoxate. Fluorocarbons and Chlorofluorocarbons alone or in combination with other propellants or refrigerants in liquefied gas form for therapeutic use. Folic acid in substances for human use except in substances containing 500 micrograms or less of folic acid per recommended daily dose. Folinic acid in substances for human use except in substances containing 500 micrograms or less of folinic acid per recommended daily dose. Halopyramine in oral substances except when included in Schedule 2. Histapyrrodine in oral substances except when included in Schedule 2. Idoxuridine in substances containing 0.5 per cent of less of idoxuridine for cutaneous use. Insulin and substances containing the specific hypoglycaemic principle of the pancreas. Mefenamic acid in packs of 30 capsules or less when labelled for treatment of spasmodic dysmenorrhea. Mepyramine in oral substances except when included in Schedule 2. Methdilazine in oral substances except when included in Schedule 2. Miconazole, for human use in preparations containing 2 per cent or less of miconazole for treatment of fungal infections of the skin. Naproxen, in packs of 12 individual dosage units, tablets or capsules, for treatment of spasmodic dysmenorrhea. Nitrofurazone in substances for cutaneous use containing 0.2 per cent or less of nitrofurazone. 26 Amendments-The Poisons Regulations of 1973 Phenindamine in oral substances except when included in Schedule 2. Pheniramine in oral substances except when included in Schedule 2. Phenyltoloxamine in oral substances except when included in Schedule 2. Podophyllum Resin (Podophyllin) for external human use in substances containing 20 per cent or less of podophyllin except when included in Schedule 2. Promethazine in oral substances except when included in Schedule 2. Pyrrobutamine in oral substances except when included in Schedule 2. Quinine for human therapeutic use. Salbutamol- (i) in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or (ii) in dry powders for inhalation capsules delivering 200 micro­ grams or less of salbutamol per dose. Santonin. Sodium Cromoglycate in nasal substances for topical use. Terbutaline in metered aerosals delivering 250 micrograms or less of terbutaline per metered dose. Thenalidine in oral substances except when included in Schedule 2. Thenyldiamine in oral substances except when included in Schedule 2. Theopylline in oral liquid substances. Tolpropamine in oral substances except when included in Schedule 2. Tretinoin for external human therapeutic use. Trimeprazine in oral substances except when included in Schedule 2. Trimethobenzamide in oral substances except when included in Schedule 2. Tripelennamine in oral substances except when included in Schedule 2. Triprolidine in oral substances except when included in Schedule 2. Amendments-The Poisons Regulations of 1973 27

SCHEDULE 4 RESTRICTED DRUGS Acepifylline except when included in Schedule 3. Acetanilide and alkyl acetanilides, for human therapeutic use. Acetazolamide. Acetohexamide. Acetylcholine and other choline esters. Acetylcysteine. Acetyldihydrocodeine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of acetyldihydrocodeine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent or less of acetyldihydrocodeine, except when included in Schedule 2. Acetyl methyl dimethyl oximido phenyl hydrazine. Acyclovir. Adiphenine. Adrenaline, natural or synthetic, in substances containing more than 1 per cent of adrenaline. Alcuronium. Allylisopropylacetylurea. Alphadolone. Alpha-receptor blocking agents including phentolamine and phenoxybenzamine. Alphaxalone. Alprazolam. Amantadine. Ambenonium. Ambucetamide. Ambutonium. Amethocaine. Amidopryine and its derivatives. Amikacin. Amiloride. Aminocaproic Acid. Aminoglutethimide. Aminometradine. Aminophylline except when included in Schedule 3. Aminopterin. Amino rex. 28 Amendments-The Poisons Regulations of 1973

Amiodarone. Amiphenazole. Amisometradine. Amitriptyline and other compounds not elsewhere specified in these Schedules, and structurally derived therefrom by substitution in the side chain. Amodiaquine. Amoxycillin. Amphomycin. Amphotericin. Ampicillin. Amylocaine. Anabolic steroidal agents. Angiotensin amide. Antazoline except when included in Schedule 2 or Schedule 3. Antibiotics not elsewhere specified in any schedule except:- (a) Avoparcin when intended for use as an animal feed additive; or (b) Nisin. Antifolic acid substances not elsewhere specified in any schedule. Antihistamines not elsewhere specified in any Schedule. Antimalarial substances not elsewhere specified in any Schedule. Antimony, organic compounds of, for therapeutic use. Antitubercular substances not elsewhere specified in any Schedule includ­ ing isoniazid and its derivatives, para-aminosalicylic acid and thiacetazone. Apomorphine. Aprotinin. Aspirin in a compounded or combined preparation for internal use which contains any caffeine, paracetamol or salicylamide. Atenolol. Atropine methonitrate. Azaperone. Azapetine. Azatadine. Azlocillin. Bacitracin except:- (a) when included in Schedule 6; or . (b) in animal feedstuffs for growth promotion in concentrations of 50 mgjkg or less of the total active antibiotic principle; or Amendments-The Poisons Regulations of 1973 29

(c) in milk replacers for calves and starter rations for pigs up to 12 weeks of age in concentrations of 100 mg/kg or less of the total active antibiotic principle. Baclofen. Bamipine except wheri included in schedule 2 or Schedule 3. Barbituric acid and its salts, and any 5,5 disubstituted derivatives of barbituric acid, whether or not further substituted at position 1 of the ring, and their salts. Beclamide. Bemegride. Benactyzine and other substances structurally derived from diphenyl- methane with ataractic properties, for therapeutic use. Benorylate. Benserazide. Benzamine except when included in Schedule 2. Benzhexol. Benzilonium. Benzocaine except when included in Schedule 2. Benzoyl peroxide in substances for external human therapeutic use, except when included in Schedule 2 or Schedule 3. Benzphetamine and other substances structurally derived from beta­ aminopropylbenzerte or beta-aminoisopropylbenzene by substitu­ tion in the side chain or by ring closure therein (or by both such substitution and such closure) except:- (a) when specifically included in this or any other Schedule; or (b) ephedrine and pseudoephedrine in substances exempted from Schedule 2. Benztropine. Benzydamine. Benzylpenicillin (including procaine penicillin) except when included in Schedule 6. Betahistine. Beta-receptor blocking agents including alprenolol and propranolol. Bethanidine. Biperiden. Bismuth compounds of, for human therapeutic or cosmetic use except:­ (a) bismuth citrate when incorporated in hair colourant prep­ arations in concentrations of 0.5% wjw or less; or (b) bismuth oxychloride in cosmetics; or (c) bismuth formic iodide in dusting powder containing 3% or less of bismuth. Bleomycin. 30 Amendments-The Poisons Regulations of 1973

Boron compounds for human therapeutic or cosmetic use except:­ (a) in dusting powders or cosmetics containing 1% or less of boron; or (b) in unit dose preparations for periodontal disease containing 100 mg or less of boron. Bretylium. Bromides, inorganic, for therapeutic use. Bromocriptine. Bromodiphenhydramine except when included in Schedule 2 or Schedule 3. Bromoform for therapeutic use. Brompheniramine except when included in Schedule 2 or Schedule 3. Bromvaletone. Buclizine except when included in Schedule 2 or Schedule 3. Bufexamac except when included in Schedule 2. Bufotenine. Bumetanide. Buniodyl sodium. Bupivacaine. Buprenorphine. Busulfan. Butacaine. Butylaminobenzoate except when included in Schedule 2. Butyl chloral hydrate. Calamus for human therapeutic use. Calcitriol. Calcium carbimide for therapeutic use. Calicitonin. Camphorated oil excluding admixtures. Camphotamide. Candicidin. Cantharidin. Capreomycin. Captodiame. Captopril. Capuride. Caramiphen. Carbachol. Carbamazepine. Amendments-The Poisons Regulations of 1973 31

Carbaryl for human therapeutic use except when included in Schedule 2. Carbazochrome. Carbenicillin. Carbenoxolone except when included in Schedule 2. Carbidopa. Carbimazole. Carbinoxamine except when included in Schedule 2 or Schedule 3. Carbocromen. Carbromal. Cardiac glycosides not elsewhere specified in any Schedule. Carindacillin. Cefaclor. Cefoperazone. Cefotaxime. Cefoxitin. Cephacetrile. Cephalexin. Cephaloridine. Cephalothin. Cephamandole. Cephapirin. Cephazolin. Cephradine. Chenodeoxycholic acid. Chloral formamide. Chloral hydrate, except in substances for topical use containing two per cent. or less of chloral hydrate. Chloramphenicol. Chlorazanil. Chlorbutol in substances for human oral use, except in substances containing 0.5 per cent. or less of chlorbutol as a preservative. Chlorcyclizine. Chlordiazepoxide and other substances structurally derived from ben- zodiazepine with ataractic properties, for therapeutic use. Chlormerodrin. Chlormethiazole. Chlormezanone. Chloroform when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. 32 Amendments-The Poisons Regulations of 1973

1-( 4-Chlorophenoxy)-1-imidazol-1-yl-3, 3-dimethyl-2-butanone for human use. 2-(4-Chlorophenyl)-1, 2, 4-triazole [5, 1a]-isoquinoline for the treatment of animals. Chloropyrilene except when included in Schedule 2 or Schedule 3. Chloroquine. Chlorothiazide and other substances structurally derived from benzo- thiadiazine, for therapeutic use. Chlorpheniramine except when included in Schedule 2 or Schedule 3. Chlorphenoxamine except when included in Schedule 2 or Schedule 3. Chlorphentermine. Chlorpromazine and other substances structurally derived from phe- nothiazine with ataractic properties, for therapeutic use. Chlorpropamide. Chlorprothixene. Chlortetracycline except:- (a) when included in Schedule 6; or (b) in animal feedstuffs containing 80 to 100 milligrams per kilogram of chlortetracycline when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age. Chlorthalidone. Chlorzoxazone. Cholestyramine for human therapeutic use. Chymopapain for human therapeutic use in substances for injection. Ciclacillin. Cimetidine. Cinchocaine. Cinnarizine except when included in Schedule 2 or Schedule 3. Cinoxacin. Cisplatin. Clanobutin for vetinerary use in substances for injection. Clavulanic Acid. Clemastine except when included in Schedule 2 or Schedule 3. Clemizole except when included in Schedule 2 or Schedule 3. Clidinium. Clindamycin. Clioquinol and other halogenated 8-Hydroxyquinoline derivatives for internal human use. Clobazam. Clobetasone-17-butyrate. Amendments-The Poisons Regulations of 1973 33

Clofenamide. Clofibrate. Clomiphene, cyclofenil and other substances specifically prepared to stimulate ovulation. Clomipramine. Clomocycline. Clonazepam. Clonidine. Clopamide. Cloprostenol for veterinary use. Clorazepate. Clorexolone. Clorprenaline. Clotrimazole. Cloxacillin. Clozapine. Codeine in compounded preparations:- (i) in tablet or capsule form containing 30 milligrams or less of codeine in each tablet or capsule; or (ii) in any other form containing one per cent. or less of codeine, except when included in Schedule 2 or Schedule 3. Colaspase. Colchicine. Colestipol for human therapeutic use. Colistin. Cortisone and steroid suprarenal cortical hormones, either natural or synthetic. . Coumarin derivatives and phenylindanedione derivatives for therapeutic use. Curare, tubocurarine, d-tubocurarine, d-tubocurarine dimethyl ether, and all synthetic quaternary ammonium compounds and other compounds having curarising properties. Cyclandelate. Cycliramine except when included in Schedule 2 or Schedule 3. Cyclizine. Cyclopentolate. Cyclopropane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Cycloserine. Cycrimine. Cyproheptadine except when included in Schedule 2 or Schedule 3. 34 Amendments-The Poisons Regulations of 1973

Dacarbazine. Danazol. Dantrolene. Dapsone and all derivatives of 4,4-diaminodiphenylsulphone. Deanol. Demecarium bromide. Demeclocycline. Deptropine except when included in Schedule 2 or Schedule 3. Desipramine. Desmopressin (D.D.A.V.P.). Dexbrompheniramine except when included in Schedule 2 or Schedule 3. Dexchlorpheniramine except when included in Schedule 2 or Schedule 3. Dextromethorphan except when included in Schedule 2. Dextropropoxyphene. Dextrorphan except when included in Schedule 2. Diazepam. Dibenzepin. Dichloralphenazone. Dichlorphenamide. Diclofenac. Dicyclomine except in substances containing 0.1 per cent. or less of dicyclomine. Diethazine. Diethylcarbamazine for human therapeutic use. Diethylpropion. N,N-Diethyltryptamine (DET). Difenoxin in preparations containing, per dosage unit, 0.5 milligram or less of difenoxin and a quantity of atropine sulphate equivalent to not less than 5 per cent. of the dose of difenoxin. Diflunisal. Digitalis and its glycosides. Dihydralazine. Dihydrocodeine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of dihydrocodeine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent. or less of dihydrocodeine, except when included in Schedule 2. Dihydrostreptomycin except when included in Schedule 6. Amendments-The Poisons Regulations of 1973 35

Diisopropylamine dichloroacetate. Dimenhydrinate except when included in Schedule 2 or Schedule 3. Dimethindene except when included in Schedule 2 or Schedule 3. Dimethisoquin except when included in Schedule 2. Dimethothiazine except when included in Schedule 2 or Schedule 3. Dimethoxanate. 2-Amino-1-(2,5-Dimethoxy-4-Methylphenyl) Propane (DOM or STP). Dimethyl sulphoxide for therapeutic use except when included in Sched- ule 6. N,N-Dimethyltryptamine. Dinitrocresols for therapeutic use. Dinitronaphthols for therapeutic use. Dinitrophenols for therapeutic use. Dinitrothymols for therapeutic use. Dinoprost for veterinary use. Diperodon. Diphemanil methylsulphate except when included in Schedule 2. Diphenhydramine except when included in Schedule 2 or Schedule 3. Diphenidol. Diphenoxylate in substances containing, per dosage unit, 2.5 milligrams or less of diphenoxylate calculated as a base and a quantity of atropine sulphate equivalent to not less than 1 per cent. of the dose of diphenoxylate. Diphenylpyraline except when included in Schedule 2 or Schedule 3. Dipivefrin. Dipyridamole. Disophenol. Disopyramide. Disulfiram for therapeutic use. Dithiazanine except when included in Schedule 6. Dobutamine. Domperidone. Dopamine. Dothiepin. Doxapam. Doxepin. Doxorubicin. Doxycycline. Doxylamine except when included in Schedule 2 or Schedule 3. Droperidol. 36 Amendments-The Poisons Regulations of 1973

Drostanolone. Econazole, except when included in Schedule 3 or Schedule 6. Edetic Acid for human therapeutic use in substances for injection or infusion. Embramine except when included in Schedule 2 or Schedule 3. Emetine except in substances containing 0.2 per cent. or less of emetine. Enflurane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Epicillin. Ergot. Erythromycin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 50 mgjkg or less of the total active antibiotic principle; or (c) in milk replacers for calves or rations for pigs up to 12 weeks of age in concentrations of 100 mgjkg or less of the total active antibiotic principle. Ethacrynic acid. Ethambutol. Ethamivan. Ethchlorvynol. Ether when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethinamate. Ethoglucid. Ethoheptazine except when included in Schedule 2. Ethopropazine. Ethoxzolamide. Ethyl Chloride when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethylene when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethylmorphine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of ethylmorphine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent. or less of ethylmorphine, except when included in Schedule 2. Ethyloestrenol. Etidocaine. Etidronate. Amendments-The Poisons Regulations of 1973 37

Etretinate. Etoposide. Fencamfamin. Fenfluramine. Fenoprofen. Fenoterol except when included in Schedule 3. Fenpipramide. Fenpiprane. Fenprostalene for veterinary use. Flavophospholipol except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle. Flucloxacillin. Flucytosine. Flufenamic acid. Flunisolide. Flunitrazepam. Flunixin Meglumine. Fluorouracil and other substances structurally derived from uracil with cytotoxic properties, for therapeutic use. Fluoxymesterone. Fluprostanol for veterinary use. Flurazepam. Fluroxene when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Fluspirilene. Framycetin. Frusemide. Fusidic Acid. Galanthamine. Gallamine. Gentamycin. Glibornuride. Gliclazide. Glucagon. Glutethimide. Glyceryl Trinitrate in substances for injection. Glycopyrrolate. Glymidine. 38 Amendments-The Poisons Regulations of 1973

Gramicidin. Griseofulvin. Guanacline. Guanethidine. Halcinonide. Haloperidol and other substances structurally derived from butyro­ phenone with ataractic properties, for therapeutic use. Halopyramine except when included in Schedule 2 or Schedule 3. Halothane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Heparin. Hetacillin. Hexachlorophane in preparations for use on infants and in all other preparations except when included in Schedule 2 or Schedule 6. Hexamethonium. Hexocyclium. Histapyrrodine except when included in Schedule 2 or Schedule 3. Hydralazine. Hydroquinone for human therapeutic use except in substances contain- ing 2 per cent. or less of hydroquinone. Hydroxycholoroquine. 1-hydroxy-pyrido (3,2,a)-5-phenoxazone-3-carboxylic acid. Hydroxyurea. Hydroxyzine. Hygromycin except:- (a) when included in Schedule 6; or (b) in substances containing 50 mgjkg or less of hygromycin. Hyoscine butylbromide. Hypothalmic releasing factors when used for diagnostic purposes. Ibufenac. Ibuprofen. Idoxuridine except when included in Schedule 3. Imipramine. Indapamide. Indomethacin. Inositol Nicotinate for internal use. Ion exchange resins, anionic and cationic, for internal human use. Ipratropium. Iron compounds, in injectable substances for human therapeutic use. Isoaminile. Amendments-The Poisons Regulations of 1973 39

Isoconazole. Isoetharine. Isometheptene. Isoprenaline. Isopropamide except when included in Schedule 2. Isoxuprine. Kanamycin. Ketamine. Ketoprofen. Khellin. Kitasamycin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 100 mgjkg or less of the total active antibiotic principle. Labetalol. Latamoxef. Laudexium methylsulphate. Lefetamine. Leptazol. Levamisole:- (i) for human therapeutic use; or (ii) in substances for the prevention or treatment of heartworm in dogs. Levodopa. Lidoflazine. Lignocaine except when included in Schedule ·2. Lincomycin. Lindane for human therapeutic use except when included in Schedule 2. Lithium salts for therapeutic use except in substances containing 0.01 per cent. or less of lithium. Loperamide. Lorazepam. Loxapine. Lymecycline. Lysergic acid. Lysergic acid diethylamide (lysergide). Maldison for human therapeutic use except when included in Schedule 2. Mafenide. Maprotiline. 40 Amendments-The Poisons Regulations of 1973

Mazindol. Mebeverine. Mebhydrolin. Mecamylamine. Meclofenoxate. Meclozine. Medazepam. Mefenamic acid except when included in Schedule 3. Mefloquine. Mefruside. Mepacrine. Mepenzolate. Mephenesin and its derivatives except guaiphenesin when included in Schedule 2. Mephentermine. Mepivacaine. Meprobamate. Mepyramine except when included in Schedule 2 or Schedule 3. Mercaptopurine and other substances structurally derived therefrom with cytotoxic properties, for therapeutic use. Mercurous Chloride for internal therapeutic use. Mercury, organic compounds of, for therapeutic use except when included in Schedule 2. Mescaline and other substances structurally derived from methoxy- phenylethylamine having hallucinogenic properties. Metaraminol. Metformin. Methacycline. Methandienone. Methandriol. Methanthelinium Methapyrilene. Methazolamide. Methdilazine except when included in Schedule 2 or Schedule 3. Methenolone. Methicillin. Methimazole. Methixene. Methocarbamol. Methotrexate. Amendments-The Poisons Regulations of 1973 41

Methoxsalen. Methoxyflurane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Methylandrostanolone. Methyl cincophen (methyl ester of phenylcinchoninic acid). Methyldopa. Methylpentynol and other substituted alkynes for internal use. Methyprylone. Methysergide. Metoclopramide. Metolazone. Metoprolol. Metrizamide. Metronidazole. Metyrapone. Mexiletine. Mezlocillin. Mianserin. Mibolerone. Miconazole except when included in Schedule 3. Minocycline. Minoxidil. Mithramycin. Mitobronitol. Mitomycin. Monensin except:- (a) in animal feedstuff containing 33 mg/kg or less ofmonensin; or (b) when included in Schedule 6. Monoamine oxidase inhibitors, including iproniazid, isocarboxazid, nialamide, phenelzine, pheniprazine and other substances for which monoamine oxidase inhibition is claimed, except triparanol. Monobenzone for human therapeutic use, except substances containing 2 per cent. or less of monobenzone. Moperone. Morphine antagonists including nalorphine, naloxone and levallorphan. Mustine and other substances structurally derived therefrom with cyto- toxic properties, for therapeutic use. Nalbuphine. Nalidixic acid. Nandrolone. 42 Amendments-The Poisons Regulations of 1973

Naproxen except when included in Schedule 3. Narasin except:- (a) when included in Schedule 6; or (b) in animal feeds containing 100 mg/kg or less of narasin. Natamycin except when used as a permitted food additive. Neomycin except when included in Schedule 6. Neostigmine. N etilmicin. Nicocodine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of nicocodine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent. or less of nicocodine, except when included in Schedule 2. Nicodicodine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of nicodicodine in each tablet or capsule; or (ii) in any form containing 2.5 per cent. or less of nicodicodine, except when included in Schedule 2. Nicotine in chewing tablets containing 4 milligrams or less of nicotine per tablet when labelled for use as an aid in withdrawal from tobacco smoking. Nicotinic Acid, when the recommended daily dose exceeds 250 mg. Nicotinyl alcohol for internal use. Nifedipine. Nifenazone. Nikethamide. Niridazole. Nitrazepam. Nitrofuran and its derivatives for human therapeutic use except when included in Schedule 3. Nitrous Oxide when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. N omifensine. Noradrenaline excluding its derivatives. Norcodeine in compound preparations:- (i) in tablet or capsule form containing 100 milligrams or less of norcodeine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent. or less of norcodeine, except when included in Schedule 2. N orethandrolone. Amendments-The Poisons Regulations of 1973 43

Nortriptyline. Novobiocin except when included in Schedule 6. Octamylamine. Octatropine. Oleandomycin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle. Opipramol. Orciprenaline. Organo-phosphorus compounds with anticholinesterase. activity for human therapeutic use, not elsewhere specified in any Schedule. Ornidazole. Ornipressin. Orphenadrine. Orthocaine. Orthopterin. Oxacillin. Oxandrolone. Oxazepam. Oxprenolol. Oxybuprocaine. Oxymesterone. Oxymetholone. Oxyphenbutazone. Oxyphencyclimine. Oxyphenisatin for human therapeutic use. Oxyphenonium. Oxytetracycline except:- (a) when included in Schedule 6; or (b) in animal feedstuffs containing 80 to 100 milligrams per kilogram of oxytetracycline when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age. Pamaquine. Pancuronium. Paracetamol in a compounded or combined preparation for internal use which contains any caffeine, aspirin or salicyamide. Paraldehyde. Paromomycin. Pemoline. 44 Amendments-The Poisons Regulations of 1973

Pempidine. D-Penicillamine. Pentamethonium. Penthienate. Pentolinium. Perhexilene. Phenacemide and other substances structurally derived from acetylurea with anti-convulsant properties, for therapeutic use. Phenacetin. Phenazone for internal use. Phenazopyridine. Phenethicillin except when included in Schedule 6. Phenformin. Phenglutarimide. Phenindamine except when included in Schedule 2 or Schedule 3. Pheniramine except when included in Schedule 2 or Schedule 3. Phenoxybenzamine. Phenoxymethylpenicillin except when included in Schedule 6. Phensuximide and other substances structurally derived from succinam- ide with anti-convulsant properties, for therapeutic use. Phentermine. Phenthimentonium. Phenyapin. Phenylbutazone. Phenylpropanolamine. Phenyltoloxamine except when included in Schedule 2 or Schedule 3. Phenytoin and other substances structurally derived from hydantoin with anti-convulsant properties, for therapeutic use. Pholcodine in compounded preparations:- (i) in tablet or capsule form containing 100 milligrams or less of pholcodine in each tablet or capsule; or (ii) in any other form containing 2.5 per cent. or less of pholcodine, except when included in Schedule 2. Physostigmine. Picrotoxin. Pilocarpine except in substances containing 0.025 per cent. or less of pilocarpine. Pimozide. Pindolol. Pipenzolate. Amendments-The Poisons Regulations of 1973 45

Pi peracillin. Piperidolate. Pipobroman. Pipradrol. Piroxicam. Pituitary, its extracts, its active principles and their synthetic substitutes. Pizotifen. Podophyllum Resin (Podophyllm):­ (i) for internal human use; or (ii) for external human use except when included in Schedule 2 or Schedule 3. Polymethylene bistrimethyl ammonium compounds. Polymyxin. Potassium perchlorate for therapeutic use. Pramoxine except when included in Schedule 2. Prazepam. Pregnenolone acetate except in substances for topical use. Prenylamine. Prilocaine. Primaquine. Primidone. Probenecid. Probucol. Procainamide. Procaine. Procarbazine. Prochlorperazine. Procyclidine except when included in Schedule 2. Proguanil. Prolintane. Promethazine except when included in Schedule 2 or Schedule 3. Propanidid. Propantheline except in substances for topical use. Propoxur for human therapeutic use except when included in Schedule 2. Propylhexedrine except when included in Schedule 2. Proquazone. Prostaglandins except where elsewhere specified in this Schedule. Prostainol for veterinary use. Prothionamide. 46 Amendments-The Poisons Regulations of 1973

Protriphyline. Proxymetacaine. Psilocin. Psilocybin. Pyridostigmine. Pyrimethamine. Pyrrobutamine· except when included in Schedule 2 or Schedule 3. Quinethazone. Quinidine. Ranitidine. Rauwolfia Serpentina. Riofampicin. Ritodrine. Roliteracycline. Rosoxacin. Salbutamol except when included in Schedule 3. Salicylamide in a compounded or combined preparation for internal use which contains any caffeine, aspirin or paracetamol. Salinomycin except:- (a) in animal feeds containing 60 mgjkg or less of the total active principle; or (b) when included in Schedule 6. Selenium except:- (a) when included in Schedule 5 or Schedule 6; or (b) in prepared stock feeds containing 0.1 grams per tonne or less of selenium; (c) in compressed pellets for control of selenium responsive conditions in sheep. Sex Hormones, natural or synthetic, their substitutes, in all preparations including cosmetics except:- (a) their derivatives and their substitutes without sex hormonal activity; or (b) where elsewhere specified. Silver Sulphadiazine. Sisomycin. Sodium Cromoglycate except when included in Schedule 3. Sodium Fluoride in substances for human ingestion except when included in Schedule 2. Sodium Nitroprusside for human therapeutic use. Sodium Valproate. Sontoquine. Amendments-The Poisons Regulations of 1973 47

Sparteine. Spectinomycin. Spiramycin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in pigs or poultry in concentrations of 50 mg/kg or less of the total active antibiotic principle. Spironolactone. Stanolone. Stanozolol. Streptomycin except when included in Schedule 6. Strophanthus and its glycosides. Strychnine in substances containing 1.5 per cent. of less of strychnine for veterinary use. Sulfametrole. Sulindac. Sulphanilamide and its derivatives except:­ (a) when included in Schedule 6; or (b) sulphaquinoxaline when incorporated in baits for the destruction of vermin and in animal feedstuffs containing 200 mgjkg or less of sulphaquinoxaline; or (c) oryzalin; or (d) in animal feedstuffs containing 80 to 100 milligrams per kilogram of sulphanilamide substance when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age; or (e) where elsewhere specified. Sulphatroxazole for veterinary use. Sulphinpyrazone. Sulphomyxin. Sulphonal and alkyl sulphonals. Sulthiame. Suxamethonium. Tacrine. Tamoxifen. Temazepam. Teniposide. Terbutaline except when included in Schedule 3. Teropterin. Tetrabenazine. Tetracycline except when included in Schedule 6. 48 Amendments-The Poisons Regulations of 1973

Thalidomide. Thenalidine except when included in Schedule 2 or Schedule 3. Thenyldiamine except when included in Schedule 2 or Schedule 3. Theophylline except when included in Schedule 3. Thiacetarsamide, in substances for the prevention or treatment of heartworm in dogs. Thiambutosine. Thiazosulphone. Thiotepa and other substances structurally derived therefrom with cyto­ toxic properties, for therapeutic use. Thiothixene. Thiouracil and substances structurally derived therefrom with anti- thyroid properties, for therapeutic use. Thiourea for therapeutic use. Thyroid and its extract, and its active principles. Tiamulin except:- (a) when included in Schedule 6; or (b) in prepared animal feeds. T icarcillin. Tiemonium. Tigloidine. Timolol. Tinidazole. Tipepidine. Tobramycin. Tocainide. Tolazamide. Tolazoline for internal use. Tolbutamide. Tolpropamine except when included in Schedule 2 or Schedule 3. Tranexamic acid. Tretamine. Triamterene. Triaziquone. Triazolam. Trichloroethylene when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Triclofos. Tricyclamol. Tridihexethyl. Amendments-The Poisons Regulations of 1973 49

Trifluperidol. Trimeprazine except when included in Schedule 2 or Schedule 3. Trimetaphan. Trimethobenzamide except when included in Schedule 2 or Schedule 3. Trimethoprim. Trimipramine and other compounds structurally derived therefrom by substitution in the side chain. Trimustine. Trioxysalen. Triparanol. Tripelennamine except when included in Schedule 2 or Schedule 3. Triprolidine except when included in Schedule 2 or Schedule 3. Troxidone and other substances structurally derived from oxazolidinone with anti-convulsant properties, for therapeutic use. Tylosin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 50 mgjkg or less of the total active antibiotic principle; or (c) in milk replacers for calves or rations for pigs up to 12 weeks of age in concentrations of 100 mgjkg or less of the total active antibiotic principle. Urethane (excluding its salts) for therapeutic use. Urethanes and ureides having or purporting to have soporific, hypnotic or narcotic properties, not specifically included in this or any other Schedule. Vaccines, sera, toxoids, antitoxins and antigens for human parenteral use. Vaccines, veterinary live virus, except those included in Schedule 6. Valnoctamide. Verapamil. Veratrum for therapeutic use. Vidarabine. Vinca alkaloids including semi-synthetic derivatives. Vinyl Ether when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Viprynium. Virginiamycin except:- (a) when included in Schedule 6; or (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle. 50 Amendments-The Poisons Regulations of 1973

Visnadine. Vitamin A in substances for human use containing more than 3 mil­ ligrams (10 000 International units) per recommended daily dosage. Vitamin D in substances for human use containing more than 25 micrograms (1 000 International Units) per recommended daily dosage. Xanthine oxidase inhibitors including allopurinol. Xanthinol nicotinate. Xylazine. Yohimbine. Zeranol except when included in Schedule 6. Amendments-The Poisons Regulations of 1973 51

SCHEDULE 5 POISONS Acetic acid (excluding its salts) and substances containing more than 30 per cent. acetic acid except:- (a) when included in Schedule 2 or Schedule 6; or (b) for therapeutic use. Acetic anhydride (excluding its salts) and substances containing more than 30 per cent. acetic anhydride, except:- (a) when included in Schedule 6; or (b) for therapeutic use. Acetone except:- (a) in substances containing 25 per cent. or less of ketones included in Schedule 5; or (b) in containers having a capacity of more than 20 litres provided the containers are marked with the name(s) and proportion(s) of ketones included in Schedule 5. Aklomide. Alachlor. Alkaline salts, being the carbonate, orthosilicate, metasilicate or tribasic phosphate salts of sodium or potassium, or any combination, except:- (a) in substances containing 10 per cent. or less of combined substances; or (b) in solid substances whose pH in 1 per cent. (wjv) aqueous solution is 11.5 or less; or (c) in liquid substances having a pH of 11.5 or less. Alloxydim. Ametryn. Alpha-(2-chlorophenyl)-alpha-( 4-chlorophenyl)-5-pyrimidinemethanol. Amitrole. Ammonia (excluding its salts other than ammonium hydroxide) in substances containing 5 per cent. or less of free ammonia except:- (a) in medicinal preparations for internal use; or (b) in appliances for inhalation in which the substance is absorbed upon an inert solid material; or (c) in substances containing 0.5 per cent. or less of free ammonia. Ammonium thiocyanate. Arsenic, organic compounds of, not elsewhere specified in this Schedule, in herbicides or defoliants containing 3 per cent. less of arsenic. Azamethiphos. Barium silicofluoride when coated on paper in an amount not exceeding 8 milligrams per square centimetre. 52 Amendments-The Poisons Regulations of 1973

Bendiocarb in substances containing 2 per cent. or less of bendiocarb. Bentazone. Benzoyl peroxide except:- (a) when included in Schedule 2, Schedule 3 or Schedule 4; or (b) when used as an approved food additive. S-Benzyl N, N-di-(sec-butyl)-thiolocarbamate. BHC (excluding the gamma-isomer) in substances containing 10 per cent. or less of BHC. Bio allethrin except in substances containing 10 per cent. or less of bio allethrin. Bioresmethrin, except in substances containing 10 per unit or less of bioresmethrin. Boric Acid and Borax except:- (a) in substances containing 1 per cent. or less of boron; or (b) in hand cleaning preparations; or (c) when included in Schedule 4. Buthidazole. Butoxy Carboxim in solid substances containing 10 per cent. or less of butoxy carboxim. Cadmium sulphide in substances containing 2.5 per cent. or less of cadmium sulphide, for human therapeutic use. Camphor and substances containing more than 10 per cent. of camphor except when included in Schedule 4. Carbaryl:- (i) when impregnated in plastic resin strip material containing 20 per cent. or less of carbaryl; or (ii) in other substances containing 10 per cent. or less of carbaryl except when included in Schedule 2 or Schedule 4. Chlordecone in substances containing 5 per cent. or less of chlordecone. Chlorfenac. Chlorfenson. Chlorinating compounds and bleaches containing more than 4 per cent. of available chlorine, except where elsewhere specified. Chlornidine. Chlorocresol and substances containing more than 3 per cent. chlorocresol. 2-Chloro-N- ( 4-Methoxy-6-Methyl-1 ,3,5,-Triazin-2-YL) Aminocarbonyl Benzene Sulphonamide. 1-( 4-Chlorophenoxy)-1-imidazol-1-yl-3, 3-dimethyl-2-butanone in sub­ stances containing more than 2 per cent. of 1-(4-chlorophenoxy)- 1-imidazol-1-yl-3, 3-dimethyl-2-butanone except when included in Schedule 4 or Schedule 6. Chloropropylate. Amendments-The Poisons Regulations of 1973 53

Chlorothalonil. Clanobutin for veterinary use except when included in Schedule 4. Clofentezine. Copper sulphate except for internal therapeutic use. 4-CPA. Cuprimyxin for veterinary use. Cyanatryn. Cyanoacrylic Acid Esters. Cyanuric acid (excluding its salts). Cyclohexanone peroxide. Cypermethrin in substances containing 10 per cent. or less of cypermethrin. 2, 4-D. S, 4-DB. 2, 4-DES. N, N-Diallyldichloroacetamide, except in substances containing 10 per cent. or less of N, N-diallyldichloroacetamide. Dicamba. Dichlone. Dichloroisocyanurates in substances containing more than 4 per cent available chlorine. 1-[2-(2,4-Dichlorophenyl)-4-propyl-1, 3-dioxalan-2-ylmethyl]-1 H 1, 2, 4- triazole, in substances containing 20 per cent. or less of 1-[2-(2, 4- Dichlorophenyl)-4-propyl-1, 3-dioxalan-2-ylmethyl]-1 H 1, 2, 4- triazole. 1-2 (2, 4-Dichlorophenyl)-2-(2-propenyloxy) ethyl-1h-imidazole. 3-6-Dichloropicolinic acid. Dichlorvos:- (i) when impregnated in plastic resin strip material containing 20 per cent. or less of dichlorvos; or ' (ii) in sustained release resin pellets for veterinary use containing 20 per cent. or less of dichlorvos; or (iii) in aerosol packs containing 10 grams or less of dichlorvos. Dicloran. Dicofol. Dicophane in substances containing 10 per cent. or less of dicophane, except for human therapeutic use. Dimethirimol. Dimethylformamide, in substances containing 10 per cent. or less of dimethylformamide. Dinitramine. Diphenamid. 54 Amendments-The Poisons Regulations of 1973

Do dine. DSMA in herbicides or defoliants containing 3 per cent. or less of arsenic. Epoxy resins, liquid, and all amines and organic anhydrides used as curing agents for epoxy resins. EPTC. Ethephon (excluding its salts). Ether preparations for use in internal combustion engines. Ethofumesate. 2-1-(Ethoxyimino) Butyl-5 (2-Ethylthiopropyl)-3-Hydroxy-2-Cycloh­ exen-1-0ne (Sethoxydim). Ethoxyquin except in substances containing 10 per cent. or less of ethoxyquin. Ethylene glycol, when packed and labelled as a boiling point and/or freezing point modifier and containing 10 milligrams per kilogram of denatonium benzoate as a bittering agent. Fenarimol. Fenbutatin-oxide. Fenoprop. Penson. Fenthion in substances containing 20 per cent. or less of fenthion packed in single use containers having a capacity of 1.0 millilitre or less. Flam prop-methyl. Fluchloralin. Flumethrin in substances containing one per cent or less of flumethrin. Formic acid (excluding its salts). Fospirate when impregnated in plastic resin strip material containing 20 per cent. or less of fospirate. Furalaxyl. Glutaraldehyde, in substances containing 5 per cent. or less of glutar- aldehyde, except when included in Schedule 2. Glyphosate. Hexazinone. Hyrqcarbons, Liquid, including kerosene, mineral turpentine, white 'petroleum spirit, toluene, xylene and light mineral and paraffin oils distilling under 300°C, except:- (a) toluene and xylene when included in Schedule 6; or (b) in containers having a capacity of more than 20 litres provided the containers are marked with the name(s) and proportion(s) of hydrocarbons; or (c) in solid or semi-solid cleaning and polishing substances; or (d) in substances containing 25 per cent. or less of a total of such liquid hydrocarbons; or Amendments-The Poisons Regulations of 1973 55

(e) in substances packed in pressurised aerosol containers; or (f) in adhesives packed in containers each containing 50 grams or less of adhesive. Hydrochloric acid (excluding its salts) in substances containing 10 per cent. or less of hydrochloric acid (HCl) except:- (a) in substances containing 0.5 per cent. or less of hydrochloric acid (HCl); or (b) for therapeutic use. Hydrofluoric acid and hydrosilicofluoric acid in substances containing 0.5 per cent. or less of hydrofluoric acid or hydrosilicofluoric acid except in substances containing 15 mgjkg or less of fluoride ion. Hydrogen peroxide (excluding its salts) and substances containing more than 6 per cent. weight in volume (20 vol.) of hydrogen peroxide. Iodofenphos. Isopropyl-N -(3-N -ethyl-N -phenylcarbamoyloxy) phenylcarbamate. Levamisole in substances containing 15 per cent. or less of levamisole for veterinary use, except when included in Schedule 4. Lindane in substances containing 10 per cent. or less of lindane except when included in Schedule 2 or Schedule 4. Maldison in substances containing 10 per cent. or less of maldison, except:- (a) when included in Schedule 2 or Schedule 4; or (b) in dust preparations containing 2 per cent. or less ofmaldison. Mancozeb. Maneb. MCPA. MCPB. Mecoprop. Mepiquat. Metaldehyde in substances containing 2 per cent. or less of metaldehyde. Methabenzthiazuron. Methazole. Methiocarb in pelleted substances containing 2 per cent. or less of methiocarb. Methoxychlor. Methylated Spirit, Industrial as defined by the Commonwealth Spirit Act 1906-1973 (excluding its admixtures and preparations) when packed in containers having a capacity of 5 litres or less. Methylene chloride except in substances packed in pressurised aerosol containers. Methyl ethyl ketone except:- (a) in substances containing 25 per cent or less of ketones included in this Schedule; or 56 Amendments-The Poisons Regulations of 1973

(b) in containers having a capacity of more than 20 litres provided the containers are marked with the name(s) and proportions(s) of ketones included in this Schedule. Methyl ethyl ketone peroxide. Methyl iso-amyl ketone except:- (a) in substances containing 25 per cent or less of ketones included in this Schedule; or (b) in containers having a capacity of more than 20 litres provided the containers are marked with the name(s) and proportion(s) of ketones included in this Schedule. Methyl isobutyl ketone except:- (a) in substances containing 25 per cent or less of ketones included in this Schedule; or (b) in containers having a capacity of more than 20 litres provided the containers are marked with the name(s) and proportion(s) of ketones included in this Schedule. Methyl N-(methoxyacetyl)-N-(2, 6-xylyl) alaninate. Methyl Salicylate in liquid substances containing 25 per cent or more of methyl salicylate except when included in Schedule 6. Metiram. Metolachlor. Metribuzin. Mezineb. MSMA in herbicides or defoliants containing 3 per cent or less of arsemc. Naled when impregnated in plastic resin strip material containing 20 per cent. or less of naled. Naptalam. Naphthalene (excluding its salts). Naphthalene acetic acid except in substances containing 25 per cent. or less of napthalene acetic acid. Nitric acid (excluding its salts) in substances containing 10 per cent. or less W/W of nitric acid (HN03), except substances containing 0.5 per cent. or less of nitric acid (HN03). Norbormide. Ofurace. Organo-tin compounds not elsewhere included in this Schedule in substances containing 1 per cent. or less of such compounds. Ortho phenylphenol except in substances containing 3 per cent or less of orthophenylphenol. Oxycarboxin. Oxythioquinox. Para-dichlorobenzene. Amendments-The Poisons Regulations of 1973 57

Pebulate. Pendimethalin. Peracetic Acid in substances containing 10 per cent or less of peracetic acid. Petrol and substances containing more than 25 per cent. of petrol when packed in containers of 20 litres or less. Phosphonic Acid except in substances containing 10 per cent or less of phosphonic acid. Phosphoric acid, excluding it salts except:- (a) when packed in containers with a capacity of not less than 10 litres and labelled with the word "CORROSIVE", in bold face sanserif capital letters of a height of not less than 1 em; or (b) in substances containing 350 g per litre or less of phosphoric acid; or (c) in solid and semi-solid preparations; or (d) in professional dental kits. Pirimicarb in substances containing 0.5 per cent. or less of pirimicarb. Poly (hexamethylene biguanide) except in substances containing 5 per cent or less of poly (hexamethylene biguanide). Potassium hydroxide in substances containing 5 per cent. or less of potassium hydroxide except:- (a) substances containing 0.5 per cent. or less of potassium hydroxide; ·or (b) in accumulators and batteries. Potassium Sulphide in substances for metal treatment when packed in containers each holding 50 grams or less of potassium sulphide. Prometryn. Propanil. Propionic acid (excluding its salts) in substances containing more than 30 per cent propionic acid, except:- (a) when included in Schedule 6; or (b) for therapeutic use. Propoxur:- (i) in dust preparations containing 3 per cent. or less of pro­ poxur; or (ii) in granular sugar based fly baits containing, (a) 1 per cent or less of propoxur; and (b) an approved colouring agent; and (c) an approved bittering agent; or (iii) in aerosol packs containing 10 grams or less of propoxur. Prynachlor. 58 Amendments-The Poisons Regulations of 1973

Pyrethrins, naturally occurring, being pyrethrolone cinerolone or jas­ molone esters of chrysanthemic or pyrethric acids except in sub­ stances containing 1 per cent or less of such pyrethrins. Pyrinuron in substances containing 10 per cent or less of pyrinuron. Quaternary ammonium compounds and substances containing more than 10 per cent. of quaternary ammonium compounds, except when included in another Schedule. Quintozene. Salicylanilide. Selenium sulphide in substances contammg 2.5 per cent. or less of selenium sulphide for topical therapeutic use. Sinbioallethrin except in substances containing 10 per cent or less of Sinbioallethrin. Sodium chlorate. Sodium hydrogen sulphate. Sodium hydroxide in substances containing 5 per cent. or less of sodium hydroxide, except substances containing 0.5 per cent. or less of sodium hydroxide. Sodium nitrite except:- (a) in substances containing 1 per cent. or less of sodium nitrite; or (b) when included in Schedule 2. Sodium Sulphide in substances for metal treatment when packed in containers each holding 50 grams or less of sodium sulphide. Styrene except in containers having a capacity of more than 20 litres provided the containers are marked with the name and proportion of styrene. Sulphamic acid, except in substances containing 10 per cent or less of sulphamic acid. 2,3,6-TBA. TDE in substances containing 10 per cent. or less of TDE. Terbumeton. Terbutryn. Tetrachloroethylene in substances containing 5 per cent. or less of tetrachloroethylene except:- (a) for therapeutic use; or (b) when absorbed into an inert solid. Tetrachlorvinphos except in animal feedstuffs containing 0.2 per cent. or less of tetrachlorvinphos. Tetramethrin except in aerosol packs. Thiobencarb. Triadimefon when packed as wettable powder containing less than 25 per cent. of triadimefon. Amendments-The Poisons Regulations of 1973 59

Triadimenol. Tri-allate. Trichloroacetic acid (alkali salts of). 1,1, 1-Trichloroethane when packed in containers of 20 litres or less except:- (a) in substances containing 25 per cent. or less of 1,1, !-trich­ loroethane; or (b) in substances packed in pressurised aerosol containers other than for therapeutic use; or (c) in containers having a capacity of more than 20 litres provided the containers are marked with the name and proportion of 1, 1, 1-trichloroethane. Trichloroisocyanuric acid when compressed in block form for use in swimming pools. Trietazine. Turpentine Oil when packed in containers of 20 litres or less except in substances containing 25 per cent or less of turpentine oil. Vernolate. Warfarin in rodent baits containing 0.1 per cent or less of warfarin. Zinc pyrithione in substances containing 2 per cent. or less of zinc pyrithione. Zineb. Ziram. 60 Amendments-The Poisons Regulations of 1973

SCHEDULE 6 POISONS Acephate. Acetic acid (excluding its salts) and substances containing more than 80 per cent. of acetic acid except when included in Schedule 2. Acetic Anhydride (excluding its salts) and substances containing more than 80 per cent. of acetic anhydride except for therapeutic use. Acifluorfen. Aldrin. Allicdochlor. Alpha-Chlorohydrin. Alpha-Chloralose when prepared for use as a pesticide. Amidithion. 2-amino-butane. Aminocarb in substances containing 25 per cent. or less of aminocarb. 2-Amino-5-diethylamino toluene. 2-Amino-5-N-ethyl-N-B (hydroxy ethyl) amino toluene. 2-Amino-5-N-ethyl-N-B (methane sulphonamide ethyl) amino toluene. 2-Amino-5-N-ethyl-N-B (methoxyethyl amino toluene) di-p-toluene. Amitraz. Ammonia (excluding its salts other than ammonium hydroxide) except:­ (a) in substances containing 5 per cent. or less of free ammonia; or (b) in medicinal preparations for internal use; or (c) in appliances for inhalation in which the substance is absorbed upon an inert solid material. Aniline (excluding its salts) and substances containing more than 1 per cent. of aniline. Arecoline. Arsenic, not elsewhere specified in this Schedule:- (i) in ant poisons containing 0.5 per cent. or less arsenic trioxide; or (ii) organic compounds of arsenic in herbicides or defoliants except when included in Schedule 5; or (iii) in animal feedstuff premixes containing 4 per cent. or less of arsenic: or (iv) in substances for veterinary use except thiacetarsamide when included in Schedule 4. Azobenzene. Azocyclotin. Amendments-The Poisons Regulations of 1973 61

Bacitracin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Barban. Barium, salts of (except barium sulphate) except when included in Schedule 5. Bendiocarb:- (i) in wettable powder containing 80 per cent. or less of ben­ diocarb and when packed in containers or primary packs containing not less than 100 grams of bendiocarb; or (ii) in wettable powder containing 20 per cent or less of ben­ diocarb and not less than 0.002 of denatonium benzoate when packed and labelled as a flybait in containers of not less than 48 grams; or (iii) in insoluble granular substances containing 5 per cent. or less of bendiocarb; or (iv) except when included in Schedule 5. Benomyl. Benquinox. Bensulide. 5-Benzylfur-3-Ylmethyl ( 1'R,3'S.E. )-2',2'-Dimethyl-3'-(2-0xo-2,3,4,5- Tetrahydro-3-Thienylidenemethyl)-Cyclopropane Carboxylate. Benzylpenicillin including procaine penicillin in substances for intra­ mammary infusion in animals, containing not more than 100,000 international units per dose of benzylpenicillin or procaine peni­ cillin, when packed in applicator devices specially designed for the purpose. Beryllium. BHC (excluding the gamma-isomer) except when included in Schedule 5. Binapacryl. Bithionol for the treatment of animals. Bromadiolone in substances containing 0.1 per cent. or less of bromadiolone. Brodifacoum in substances containing 0.25 per cent. or less of brodifacoum. Bromoform, except for therapeutic use. Bromophos. Bromophos-ethyl. Bromoxynil. Brotianide. Bunamidine. Butacarb. 62 Amendments-The Poisons Regulations of 1973

Butoxycarboxim except when included in Schedule 5. 2-butoxy-2 1-thiocyano-diethyl ether. Butynorate. Cacodylic Acid in animal feed premixes containing 4 per cent. or less of arsenic. Cadmium, compounds of, except when included in Schedule 5. Cambendazole. Carbadox except in animal feedstuffs containing 50 mg/kg or less of the total active principle. Carbaryl except when included in Schedule 2, Schedule 4 or Schedule 5. Carbendazim. Carbon disulphide. Chlordane. Chlordecone except when included in Schedule 5. Chlorfenethol. Chlormequat. N -( 5-Chloro-4-( ( 4-chloropheny 1)-cyanomethyl)-2- methylphenyl)-2- hydroxy-3,5-diiodobenzamide. Chloromethiuron. Chlorophacinone. 1-( 4-Chlorophenoxy)-1-imidazol-1-yl-3, 3-dimethyl-2-butanone in sub­ stances containing more than 40 per cent. of 1-(4-Chlorophenoxy)- 1-imidazol-1-yl-3, 3-dimethyl-2-butanone except when included in Schedule 4. Chloropicrin in substances containing 5 per cent. or less of chloropicrin. 5-(2-chloro-4(trifluoromethyl) phenoxy)-2-Nitrobenzoate. Chlorpyrifos. Chlorpyrifos-methyl. Chlortetracycline in substances:- (i) for topical application to animals for ocular use only; or (ii) for intramammary infusion in animals, containing not more than 100,000 international units per dose of chlortetracyc­ line, when packed in applicator devices specially designed for the purpose; or (iii) for feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of antibiotic substance when labelled for the preparation of feeds containing 80 to 100 milligrams per kilogram of antibiotic substance. Chlorthiamid. Chromates and dichromates. Chromium trioxide (excluding its salts). Amendments-The Poisons Regulations of 1973 63

Coumaphos in substances containing 5 per cent. or less of coumaphos. Coumarin derivatives and phenylindanedione derivatives not otherwise included in any Schedule. Coumatetralyl. Crotoxyphos. Crufomate. Cyanazine. Cyhexatin. Cyometrinil. Cypermethrin except when included in Schedule 5. Cythioate. Dazomet. Deltamethrin in aqueous formulation containing 1 per cent. or less of deltamethrin, when no other organic solvent, other than a glycol, is present. Demeton-0-methyl and demeton-S-methyl in substances containing 50 per cent. or less of one or both demeton-0-methyl and demeton­ S-methyl. Di-allate. Diazinon. Dichlofenthion. Dichloroethyl ether. 1-(2-(2,4-Dichlorophenyl)-4-ethyl-1 ,3-dioxolan-2-yl-methyl)-1 h-1 ,2,4- triazole. 1-2-(2,4-Dichlorophenyl)-4-Propyl-1 ,3-Dioxalan-2-Ylmethyl-IH -1,2,4- Triazole, except when included in Schedule 5. N-(3,4-Dichlorophenyl)-N'-2-(2" Sulfoxy-4'-Chlorphenoxy)-5 Chlor- phenyl Urea (Soduim Salt). Dichloropropane. Dichloropropene. Dichlorvos in substances containing 50 per cent. or less of dichlorvos except when included in Schedule 5. Diclofop-methyl. Dicophane and substances containing more than 10 per cent. of dico- phane except for human therapeutic use. Dieldrin. Diethylene dioxide. N,N-Diethyl-p-phenylene diamine. Difenzoq uat. 2,3-Dihydro-5,6-Dimethyl-1 ,4-Dithiin-1, 1,4,4- Tetraoxide. Dihydrostreptomycin in subtances for intramammary infusion in ani- mals containing not more than 100,000 international units per dose 64 Amendments-The Poisons Regulations of 1973

of dihydrostreptomycin, when packed in applicator devices specially designed for the purpose. Dimethanonaphthalene and all substitution and/or addition products of, not elsewhere specified in any schedule. Dimethoate. 1,3-di (methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate in sub­ stances containing 25 per cent. or less of 1,3-di (methoxycarbonyl)- 1-propen-2-yl-dimethyl phosphate. Dimethyl-formamide except when included in Schedule 5. 2-(2', 4'-Dimethyl-phenylimino )-3-methyl-4-thiazoline. Dimethyl Sulphoxide:- (i) when not packed and labelled for therapeutic use; or (ii) for veterinary use when combined with no other therapeutic substance; or (iii) for veterinary therapeutic use in preparations containing copper salicylate as the only other therapeutically active ingredient. Dimetilan in subtances containing 25 per cent. or less of dimetilan. Dimetridazole. Dinitrocresols and their homologues not elsewhere specified in this Schedule, in substances containing 5 per cent. or less of such compounds except when included in Schedule 4. Dinitrophenols and their homologues not elsewhere specified in this Schedule, in substances containing 5 per cent. or less of such compounds except when included in Schedule 4. Dinocap. Dinoseb in substances containing 5 per cent. or less of dinoseb. Dioxacarb. Diphacinone. Diquat. Disulfiram except when included in Schedule 4. Disulphoton in granular preparations containing 5 per cent. or less of disulphoton. Dithianon Dithiazanine in substances containing 2 per cent. or less of dithiazanine for veterinary use. Dithiocarbamates when packed for use for agricultural, pastoral or horticultural purposes, except when included in Schedule 5. 3,3'-Di-(trifluoromethyl)-4, 4'-dichloro-n, n'-diphenyl urea. Diuredosan. DSMA in herbicides or defoliants except when included in Schedule 5. Econazole, for external veterinary use. Endosu1fan. Amendments-The Poisons Regulations of 1973 65

Endothal. Epichlorohydrin except in substances containing 2 per cent. or less of epichlorohydrin. Erythromycin:- (i) in substances for intramammary infusion in animals, con­ taining not more than 100,000 international units per dose of erythromycin, when packed in applicator devices specially designed for the purpose; or (ii) in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 mg/kg but not more than 20,000 mg/kg of the total antibiotic principle. Ether solvent. Ethiofencarb. Ethoate-methyl. Ethoprophos in granular formulations containing 10 per cent. or less of ethoprophos. Ethyl bromide. Ethylene chlorohydrin. Ethylene dichloride. Ethylene Glycol when packed and labelled as a boiling point and/or freezing point modifier except when included in Schedule 5. Ethylene oxide. Etridiazole. Eucalyptus Oil except in substances containing twenty-five per cent. or less of eucalyptus oil. Famphur in substances containing 20 per cent. or less of famphur. Fenaminosulf in substances containing 10 per cent. or less of fenami­ nosulf when labelled and packed as dry seed dressing. Fenamiphos in granular preparations containing 5 per cent. or less of fenamiphos. Fenazaflor. Fenchlorphos. Fenitrothion. Fenthion except when included in Schedule 5. Fen valerate. Fer bam. Ferrocyanides and ferricyanides except in substances containing 1 per cent. or less of such substances. Flavophospholipol in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 mg,!kg but not more than 20,000 mg/kg of the total antibiotic principle. Fluazifop-ButyL racemate and R-enantiomer. Flumethrin except \-Vhen mcluded in Schedule 5. 66 Amendments-The Poisons Regulations of 1973

Formaldehyde and substances containing more than 5 per cent. of formaldehyde. Formothion. Fospirate except when included in Schedule 5. Fumagillin. Glutaraldehyde except when included in Schedule 2 or Schedule 5. Guazatine. Haloxon. Heptachlor. Hexachlorobenzene. Hexachlorophane in substances for the treatment of animals. Hydrazine. Hydrochloric acid (excluding its salts) and substances containing more than 10 per cent. by weight of hydrochloric acid (HC1) as such. Hydrofluoric acid and hydrosilicofluoric acid and other fluorine com­ pounds; except:- (a) when used for human therapeutic purposes; or (b) in dentrifrices containing 0.5 per cent. or less of fluoride ion; or (c) in substances containing 3 per cent. or less of sodium fluoride or sodium silicofluoride when used as preservatives; or (d) when included in Schedule 2, Schedule 4, Schedule 5 or Schedule 7; or (e) in substances containing 15 mgjkg or less of fluoride ion; or (f) Ammonium fluosilicate in substances containing 3.2 per cent. or less of ammonium fluosilicate for pesticide purposes. Hydroquinone except:- (a) when included in Schedule 4; or (b) substances containing 10 per cent. or less of hydroquinone. Hygromycin in animal feedstuff premixes for use as an anthelmintic containing concentrations greater than 50 mg/kg but not more than 20,000 mg/kg of hygromycin. Imidocarb. Iodine (excluding its salts, derivatives and iodophors) except:­ (a) when included in Schedule 2; or (b) in solid or semi-solid substances containing 2.5 per cent. or less of available iodine. Iodophors except in preparations containing 1.5 per cent or less of available iodine. Ioxynil. Amendments-The Poisons Regulations of 1973 67

Iron compounds and substances containing more than 5 per cent of iron for veterinary use. Isocyanates, free organic. Kitasamycin in animal feedstuff premixes for growth promotion pur­ poses containing concentrations greater than 100 mg/kg but not more than 20,000 mg/kg of the total antibiotic principle. Lasalocid except in animal feedstuffs containing 100 mg/kg or less of the total antibiotic principle. Laurylisoquinolinium bromide. Lead compounds except:- (a) in substances for therapeutic use; or (b) in substances for cosmetic use, except when included m Schedule 5, or containing 250 ppm or less of lead. Levamisole for the treatment of animals except where included m Schedule 4 or Schedule 5. Lindane except when included in Schedule 2, Schedule 4 or Schedule 5. Maldison except:- (a) when included in Schedule 2, Schedule 4 or Schedule 5; or (b) in dust preparations containing 2 per cent or less of maldison. Mebendazole for veterinary use. Meclofenamic acid for veterinary use. Menazon. Mercuric iodide when packed for use for agricultural, industrial, pastoral or horticultural purposes. Mercuric thiocyanate when packed for photographic purposes. Mercurous chloride except when included in Schedule 4. Mercury, organic compounds of, in substances for agricultural, pastoral, or horticultural use except ethoxyethylmercury chloride and ethyl­ mercury chloride in Schedule 7. Metacresolsulphonic acid and formaldehyde condensation product for veterinary use. Metaldehyde except when included in Schedule 5. Methacrifos. Metham. Methiocarb except when included in Schedule 5. Methomyl in fly-baits containing one per cent. or less of methomyl and not less than 0.002 per cent. of denatonium benzoate as a bittering agent. Methyl alcohol (excluding its salts) except in methylated spirit. Methyl chloride. Methylene bisthiocyanate except in substances containing one per cent. or less of methylene bisthiocyanate. 68 Amendments-The Poisons Regulations of 1973

Methyl isothiocyanate. Methyl Salicylate excluding admixtures. 1-(B Methyl sulphonamide ethyl)-2-amino-3-N, N-diethylamino benzene. Molinate. Monensin in animal feedstuff premix containing greater than 33 mgjkg but not more than 125,000 mg/kg of the total active principle. MSMA in herbicides or defoliants except when included in Schedule 5. Naled except when included in Schedule 5. Naphthalophos when specially prepared and packed as a sheep drench. Narasin in animal feed premixes containing 120 gjkg or less of narasin. Neomycin in substances for ocular use only by topical application to animals. Nicotine in substances for veterinary use containing 3 per cent. or less of nicotine. Nimidane in substances containing 25 per cent. or less of nimidane. Nithiamide and substances containing more than 20 per cent of nithiamide. Nitric acid (excluding its salts) and substances containing more than 10 per cent. of nitric acid (HN03). Nitrobenzene except:- (a) in solid or semi-solid polishes; or (b) in soaps containing 1 per cent. or less of nitrobenzene; or (c) in substances containing 0.1 per cent. or less of nitrobenzene. Nitrophenols, ortho, meta and para. Nitroscanate. Nitroxynil. Novobiocin in substances for intramammary infusion in animals, con­ taining not more than 100,000 international units per dose of novobiocin, when packed in applicator devices specially designed for the purpose. 2-n-Octyl-4-Isothiazolin-3-one. Oestradiol-! 7-beta:- (i) in ear implants for growth promotion in bovine cattle; or (ii) in combination with progesterone, testosterone or trenbolone in ear implants for growth promotion in bovine cattle. Olaquindox when intended for use as a growth promotant in pigs, except in animal feedstuff containing 100 mgjkg or less of the total active principle. Oleandomycin in animal feedstuff premixes for growth promotion pur­ poses containing concentrations greater than 50 mgjkg but not more than 20,000 mgjkg of the total antibiotic principle. Omethoate in substances containing 50 per cent. or less of omethoate. Amendments-The Poisons Regulations of 1973 69

Organa-tin compounds, being di-alkyl, tri-alkyl and tri-phenyl tin com­ pounds where the alkyl group is methyl, ethyl, propyl or butyl not elsewhere included in these Schedules except:- (a) in plastics; or (b) in other substances containing 1 per cent. or less of such compounds. Ortho-dichlorobenzene. Oxadiazon. Oxalic acid (excluding its salts) and soluble oxalates. Oxantel pamoate for veterinary use. Oxfendazole. Oxyclozanide. Oxytetracycline in substances:- (i) for topical application to animals for ocular use only: or (ii) for intramammary infusion in animals, containing not more than 100,000 international units per dose of oxytetracycline, when packed in applicator devices specially designed for the purpose; or (iii) for feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of antibiotic substance when labelled for the preparation of feeds containing 80 to 100 milligrams per kilogram of antibiotic substance. Paraquat in granular preparations containing 3 per cent. or less of paraquat. Parbendazole. Pentachlorophenol except in substances containing 0.5 per cent. or less of pentachlorophenol. Peracetic Acid except when included in Schedule 5. Perfluidone. Permanganates. Phenethicillin in substances for intramammary infusion in animals, containing not more than 100,000 international units per dose of phenethicillin, when packed in applicator devices specially designed for the purpose. Phenkapton in substances containing 50 per cent. or less of phenkapton. Phenol and any homologue of phenol boiling below 2200C, and creosote, except:- (a) substances containing 3 per cent. or less by weight of such substances or homologues; or (b) for therapeutic use. Phenoxymethyl penicillin in substances for intramammary infusion in animals, containing not more than 100,000 international units per 70 Amendments-The Poisons Regulations of 1973

dose of phenoxymethyl penicillin, when packed in applicator devices specially designed for the purpose. Phenylene diamines and alkylated phenylene diamines not elsewhere specified in the Schedule:- (i) when used in hair dyes (excpet paraphenylenediamine); or (ii) in substances packed and labelled for photographic purposes; or (iii) in substances packed and labelled for testing water except diethyl or dimethyl paraphenylene diamine in tablets con­ taining 10 milligrams or less of diethyl or dimethyl para­ phenylene diamine in opaque strip packaging labelled for testing water. Phosalone. Phosmet. Phosphides, metallic. Phosphorus yellow (excluding its salts) in substances containing 0.5 per cent. or less of free phosphorus. Phoxim. Picric acid and substances containing more than 5 per cent. of picric acid. Pindone. Piperophos. Pirimicarb except when included in Schedule 5. Pirimiphos-ethyl. Pirimiphos-methyl. Potassium bromate and substances containing more than 0.5 per cent. of potassium bromate. Potassium cyanate. Potassium Hydroxide and substances containing more than 5 per cent. of potassium hydroxide. Prochloraz. Profenofos. Progesterone:- (i) in c:t silicone rubber elastomer when used as a controlled­ release implant for synchronisation of oestrus in cattle; or (ii) in combination with oestradiol-17-beta or trenbolone in ear implants for growth promotion in bovine cattle. Propargite. Promacyl. Promecrab in substances containing 50 per cent. or less of promecrab. Propachlor. Propetamphos. Amendments-The Poisons Regulations of 1973 71

Propionic acid (excluding its salts) except:- (a) in substances containing 80 per cent. or less of propionic acid; or (b) for therapeutic use. Propoxur except when included in Schedule 2, Schedule 4 or Schedule 5. Prothiofos. Pyrazophos. Pyrinuron except when included in Schedule 5. Rafoxanide. · Salinomycin in animal feedstuff premixes containing greater than 60 mgj kg but not more than 60,000 mg/kg of the total active antibiotic principle. Selenium, compounds of:- (i) in substances containing 2.5 per cent. or less of selenium:­ (a) when packed and labelled for the blueing of gun barrels; or (b) when packed and labelled for photographic purposes; or (ii) in substances containing 0.1 per cent. or less of selenium when packed and labelled as vaccines, drenches or pastes for treatment of animals; or (iii) in substances containing 0.5 per cent. or less of selenium when packed and labelled as other injections for treatment of animals; or (iv) in premixes containing 2 per cent. or less of selenium when packed and labelled for incorporation into animal feeds to provide 0.1 gjtonne or less of selenium. Sodium bromate and substances containing more than 0.5 per cent of sodium bromate. Sodium hydroxide and substances containing more than 5 per cent. of sodium hydroxide. Spiramycin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 mg/kg but not more than 20,000 mgjkg of the total antibiotic principle. Streptomycin in substances for intramammary infusion in animals, containing not more than 100,000 international units per dose of streptomycin when packed in applicator devices specially designed for the purpose. Sulphonamides:- (i) in substances packed and labelled for the treatment of footroot in animals in packs containing 250 grams or less of sulphonamide substance; or (ii) sulphadimidine in feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of sulphonamide substance when labelled 72 Amendments-The Poisons Regulations of 1973

for the preparation of feeds containing 80 to 100 milligrams per kilogram of sulphonamide substance; or (iii) sulphaquinoxaline when packed and labelled for use as a coccidiostat in poultry except substances containing 200 mgj kg or less of sulphaquinoxaline; or (iv) in substances packed and labelled for the treatment of ornamental caged birds or ornamental fish only. Sulphuric acid (excluding its salts) except:- (a) in accumulators, batteries or fire extinguishers; or (b) in substances containing 0.5 per cent. or less WjW of sulphuric acid (H2S04). Sulprophos. 2,4,5-T TCMTB (2-(thiocyanomethylthio) benzothiazole). TDE except when included in Schedule 5. Temephos. Terbuthylazine. Terpenes, chlorinated. Testosterone:- (i) Testosterone cypionate, dipropionate, enanthate and pro­ pionate in substances labelled for treatment and prevention of pizzle (sheath) rot in wethers; or (ii) in substances labelled for masculinisation of wethers for use as 'teaser rams' to stimulate and detect reproductive activity in ewes; or (iii) in combination with oestradiol-17-beta or trenbolone in ear implants for growth promotion in bovine cattle. Tetrachloroethylene except:- (a) for therapeutic use; or (b) in preparations containing 6 per cent or less when absorbed into an inert solid; or (c) when included in Schedule 5. Tetracycline in substances:- (i) for occular use only by topical application to animals; or (ii) for intramammary infusion in animals, containing not more than 100,000 international units per dose of tetracycline, when packed in applicator devices specially designed for the purpose; or (iii) when packed and labelled for treatment of ornamental caged birds or ornamental fish only. Tetradifon. Tetramisole in substances for veterinary use. Thallium in prepared baits containing 0.25 per cent. or less of thallium. Amendments-The Poisons Regulations of 1973 73

Thiazafluron. Thiodicarb. Thiometon. Thiourea except for therapeutic use. Thiram. Tiamulin for veterinary use:- (i) in feedstuff premixes containing 25 per cent. or less of tiamulin; or (ii) in soluble concentrates containing 45 per cent. or less of tiamulin. ortho-Tolidine when packed and labelled in concentrations of 0.1 per cent. or less of ortho-tolidine for the testing of water. Toluene except:- (a) in substances containing 50% or less of toluene or toluene and xylene; or (b) in containers having a capacity of more than 20 litres provided the containers are marked with the name and proportion of toluene or toluene and xylene. Trenbolone:- (i) in ear implants for growth promotion in bovine cattle; or (ii) in combination with oestradiol-17-beta in ear implants for growth promotion in bovine cattle. Triadimefon except when included in Schedule 5. S,S,S-tributylphosphorothiolate. Trichlorfon. Trichloroacetic Acid except when included in Schedule 5. Trichloroethylene except when included in Schedule 4. Trichlorophenol. Triclopyr. Tridemorph. Triethyl phosphate. Trifluoromethane Sulphonic Acid. Tylosin in animal feedstuff premixes for growth promotion purposes containing concetrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Vaccines, veterinary live virus, the following only­ Bovine wart vaccine, Contagious ecthyma (scabby mouth) vaccine, Fowl pox vaccine, Pigeon pox vaccine, Tick fever vaccine (babesia and anaplasma), Turkey pox vaccine. 74 Amendments-The Poisons Regulations of 1973

Vamidothion. Virginiamycin in animal feedstuff premixes for growth promotion pur­ poses containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Warfarin except:- (a) for therapeutic use; or (b) when included in Schedule 5. Xylene except:- (a) in substances containing 50% or less of xylene or xylene and toluene; or (b) in containers having a capacity of more than 20 litres provided the containers are maked with the name and proportion of xylene or xylene and toluene. Zeranol in ear implants for use as a growth promotant in steer cattle. Zinc chloride and substances containing more than 5 per cent. of zinc chloride. Zinc phenolsulphonate and substances containing more than 5 per cent. of zinc phenolsulphonate. Zinc sulphate except for human therapeutic use and in substances containing 5 per cent. or less of zinc sulphate.

APPENDIX A TO SCHEDULE 6 Arsenic and all compounds of arsenic except:- (a) when included in Schudule 4 of Schedule 7; or (b) in animal feedstuffs containing 75 mg/kg or less of arsenic; or (c) organic compounds of arsenic, other than copper acetoar­ senite, herbicides, defoliants, veterinary medicines, and ani­ mal feed additives and premixes. Beryllium. Carbon disulphide. Mercury, organic compounds of, when packed for use for agricultural, pastoral, or horticultural purposes, except when included in Sched­ ule 7. pentachlorophenol in substances containing more than 10 per cent. of pentachlorophenol. Phosphides, metallic. Amendments-The Poisons Regulations of 1973 75

SCHEDULE 7 POISONS Acrolein. Acrylonitrile. Aldicarb. Allyl alcohol. Aminocarb except when included in Schedule 6. 4-aminopyridine. Ami ton. Amygdalin. ANTU. Arprinocid. Arsenic except:- (a) thiacetarsamide when included in Schedule 4; or (b) when included in Schedule 5 or Schedule 6; or (c) in animal feedstuff containing 75 gjtonne or less of arsenic. Azinphos-ethyl Azinphos-methyl. Bendiocarb except when included in Schedule 5 or Schedule 6. Benzene except:- (a) substances containing 1.5 per cent. vjv or less of benzene; or (b) petrol containing 5 per cent. vjv or less of benzene. Beta-hydroxyethylhydrazine. Bithionol except when included in Schedule 6. 5-bromo-4-chlorosalicylanilide. Bromadiolone except when included in Schedule 6. Brodifacoum except when included in Schedule 6. Buclosamide. Camphechlor. Captafol. Carbofuran. Carbon tetrachloride. Carbophenothion. Chlordimeform. Chlorfenvinphos. Chlorine (excluding its salts). 5-Chloro-3-methyl-4-nitropyrazole. Chloropicrin and substances containing more than 5 per cent. of chloropicrin. 76 Amendments-The Poisons Regulations of 1973

Chlorthiophos. Coumaphos except when included in Schedule 6.. Cyhalothrin. Deltamethrin except when included in Schedule 6. Demeton. Demeton-0-methyl and Demeton-S-methyl except when included in Schedule 6. Dialifos. 1, 2-Dibromo-5-Chloropropane. Dichlorvos except when included in Schedule 5 or Schedule 6. Dicrotophos. Dienochlor. Dimefox. 1,3-di (methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate except when included in Schedule 6. Dimetilan except when included in Schedule 6. Dinitrocresols and their homologues not elsewhere specified in this Schedule, except when included in Schedule 4 or Schedule 6. Dinitrophenols and their homologues not elsewhere specified in this Schedule, except when included in Schedule 4 or Schedule 6. Dinoseb except when included in Schedule 6. Dioxathion. Disulphoton except in granular preparations containing 5 per cent. or less of disulphoton. Dulcin. Endrin. Ethion. Ethoprophos except when included in Schedule 6. Ethoxyethyl mercury chloride. Ethylene Dibromide. Ethyl mercury chloride. Famphur and substances containing more than 20 per cent. of famphur. Fenaminosulph except when included in Schedule 6. Fenamiphos except when included in Schedule 6. Fensulphothion. Fenthion-ethyl. Fenticlor. Flucythrinate. Flunixin Meglumine except when included in Schedule 4. Fluoroacetamide. Fluoroacetic acid. Amendments-The Poisons Regulations of 1973 77

Folpet. Formetanate. Halofuginone except in prepared stockfeeds containing 3 grams per tonne or less of halofuginone. Hydrocyanic acid and cyanides except:- (a) in substances containing the equivalent of 0.15 per cent. or less of hydrocyanic acid; or (b) for therapeutic use. Isocarbophos. Isofenphos. I vermectin. Leptophos. Mazidox. Mecarbam. Mercuric chloride when packed for agricultural, pastoral, horticultural or industrial use. Methamidophos. Methfuroxam. Methidathion. Methomyl except when included in Schedule 6. Methyl bromide. Mevinphos. Mipafox. Mirex. Monocrotophos. Naphthalophos except when specially prepared and packed as a sheep drench. Nicotine except:- (a) when included in Schedule 4 or Schedule 6; or (b) tobacco in any form. Nimidane except when included in Schedule 6. Nitrofen. Omethoate except when included in Schedule 6. Oxamyl. Oxyfluorfen. Paraquat except when included in Schedule 6. Parathion. Parathion-methyl. Phenkapton except when included in Schedule 6. Phorate. 78 Amendments-The Poisons Regulations of 1973

Phosfolan. Phosphamidon. Phosphorus, yellow (excluding its salts) in substances containing 40 g/ kg or less of yellow phosphorus when packed and labelled for the preparation of baits for the control of feral pigs. Polychlorinated biphenyls. Promecarb except when included in Schedule 6. Schradan. Strychnine except when included in Schedule 4. Sulfallate. Sulfotep. Sulphatroxazole, except when included in Schedule 4. Tepp. Terbufos. Tetrachloroethane. Tetrachlorosalicylanilide. Thallium except in prepared baits containing 0.25 per cent. or less of thallium. Thiofanox. ortho-Tolidine except when included in Schedule 6 and in solid state diagnostic therapeutic reagents. Triamiphos. Triazbutil. Trichloroisocyanuric acid except:- (a) in substances containing 4 per cent. or less of available chlorine; or (b) when included in Schedule 5. 1, 1, !-trichloroethane in aerosols for therapeutic use. Vinyl chloride (monomer). Amendments-The Poisons Regulations of 1973 79

SCHEDULE 8 DANGEROUS DRUGS Acetorphine (03-acetyl-7, 8 dihydro-7a (1 (R)-hydroxy-1-methylbutyl)- 06methyl-6, 14-endoetheno-morphine). Acetyldihydrocodeine except when included in Schedule 2 or Schedule 4. Acetylmethadol ( 3-acetoxy-6-dimethylamino-4, 4-diphenylheptane ). Alfentanil. Allylprodine (3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine ). AI phacetylmethadol (a-3-acetoxy-6-dimethylamino-4, 4-diphenylheptane ). Alphameprodine ( a-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine ). Alphamethadol ( a-6-dimethylamino-4, 4-diphenyl-3-heptanol). Alphaprodine (a-1, 3-dimethyl-4-phenyl-4-propionoxypiperidine). Amphetamine. Anileridine ( 1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester). Benzethidine ( 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester). Benzylmorphine (3-benzylmorphine ). Betacetylmethadol (~-3-acetoxy-6-dimethylamino-4, 4-diphenylheptane). Betameprodine (~- 3-ethyl-1 methyl-4-phenyl-4-propionoxypiperidine ). Betamethadol (~-6-dimethylamino-4, 4-diphenyl-3-heptanol). Betaprodine (~-1, 3-dimethyl-4-phenyl-4-propionoxypiperidine). Bezitramide ( 1-(3-cyano-3, 3-diphenylpropyl)-4-(2-oxo-3-propionyl-1- benzimidazolinyl)-piperidine). Cannabis and cannabis resin and extracts and tinctures of cannabis. Clonitazene (2-para-chlorbenzyl-1-diethylaminoethyl-5- nitrobenzimidazole ). Cocaine (methyl ester of benzoylecgonine). Coca leaf. Codeine (3-methylmorphine) except when included in Schedule 2, Sched- ule 3 or Schedule 4. Codeine-N -oxide. Codoxime (dihydrocodeinone-6-carboxymethyloxime ). Concentrate of poppy straw (the material arising when poppy straw has entered into a process for conentration of its alkaloids). Desomorphine (dihydrodesoxymorphine ). Dexamphetamine. Dextromoramide (( + )-4-(2-methyl-4-oxo-3, 3-diphenyl-4-( 1-pyrrolidinyl) butyl) morpholine). Diacetylmorphine (heroin). 80 Amendments-The Poisons Regulations of 1973

Diampromide (N-(2-(methylphenethylamino) propyl) propionanilide). Diethylthiambutene (3-diethylamino-1, 1-di-(2' -thienyl)-1 butene). Difenoxin ( 1-(3-cyano-3, 3-diphenylpropyl)-4-phenylisonipecotic acid) except when included in Schedule 4. Dihydrocodeine except when included in Schedule 2 or Schedule 4. Diphydromophine. Dimenoxadol (2-dimethylaminoethyl-1-ethoxy-1, 1-diphenylacetate). Dimepheptanol (methadol) ( 6-dimethylamino-4, 4-diphenyl-3-heptanol). 3-(1, 2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl- 6H-dibenzo (b, d) pyran (DMPH). Dimethylthiambutene (3-dimethylamino-1, 1-di-(2' thienyl-1-butene ). Dioxaphetyl butyrate (ethyl 4-morpholino-2, 2-diphenylbutyrate). Diphenoxylate ( 1-(3-cyano-3, 3-diphenylpropyl)-4-phenylpiperidine-4- carboxylic acid ethyl ester) except when included in Schedule 4. Dipipanone (4, 4-diphenyl-6-piperidine-3-heptanone ). Drotebanol (3, 4-dimethoxy-17-methylmorphinan-6, ~14-diol). Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine. Ethylmethylthiambutene (3-ethylmethlamino-1, 1-di (2' -thienyl)-1- butene). Ethylmorphine (3-ethylmorphine) except when included in Schedule 2 or Schedule 4. N-Ethyl-1-phencyclohexylamine (PCE). Etonitazene ( 1-diethylaminoethyl-2-para-ethoxybenzyl-5- nitrobenzimidazole ). Etorphine (7 .8-dihydro-7a-( 1(R)-hydroxy-1-methyl-butyl-0 6-methyl-6, 14- endoethenomorphine ). Etoxeridine ( 1-(2-(2-hydroxyethoxy) ethyl-4-phenylpiperidine-4-carox­ ylic acid ethyl ester). Fentanyl (1-phenethyl 4-N-propionyl-anilino piperidine). Furethidine ( 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-car­ boxylic acid ethyl ester). Heptane derivatives having addiction properties, not specifically included in this Schedule. 3-Hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo (b, d) pyran (parahexyl). Hydrocodone (dihydrocodeinone ). Hydromorphinol ( 14-hydroxydihydromorphine). Hydromorphone (dihydromorphinone ). Hydroxypethidine ( 4-meta-hydroxyphenyl-1-methylpiperidine-4-carbox­ ylic acid ethyl ester). Isomethadone ( 6-dimethylamino-5-methyl-4-, 4-diphenyl-3-hexanone ). Amendments-The Poisons Regulations of 1973 81

Ketobemidone. Levomethorphan ((-)-3-methoxy-N -methylmorphinan). Levomoramide ((-)-4-(2-methyl-4-oxo-3, 3-diphenyl, -4-( 1-pyrrolidinyl) butyl) morpholine). Levophenacylmorphan ((-)-3-hydroxy-N -phenamcylmorphinan). Levorphanol ((-)-3-hydroxy-N-methylmorphinan). Mecloqualone 3-(0-Chlorophenyl)-2-methyl-4-(3h) quinazolinone. Metazocine (2'-hydroxy-2, 5, 9-trimethyl-6, 7-benzomorphan). Methadone ( 6-dimethylamino-4, 4-diphenyl-3-heptanone ). Methadone-Intermediate ( 4-cyano-2-dimethylamino-4, 4-diphenyl- butane). Methaqualone. Methylamphetamine. Methyldesorphine ( 6-methyl-!::,. 6-desoxymorphine ). Methyldihydromorphine ( 6-methyldihydromorphine ). Methylphenidate. 1-methyl-4-phenylpiperidine-4-carboxylic acid esters. Metopon ( 5-methyldihydromorphinone ). Moramide-Intermediate (2-methyl-3-morpholino-1, 1-diphenylpropane carboxylic acid). Morpheridine ( 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester). Morphine. Morphine derivatives not specifically included in this Schedule. Morphine methobromide and other pentavalent nitrogen morphine derivatives. Morphine-N -oxide. Morphine substitutes not specifically included in this Schedule. Myrophine (myristylbenzylmorphine). Nabilone. Nicocodine (6-nicotinylcodeine) except when included in Schedule 2 or Schedule 4. Nicodicodine except when included in Schedule 2 or Schedule 4. Nicomorphine (3, 6-dinicotinylmorphine). N oracymethadol ( ( ± )-a-3-acetoxy-6-methylamino-4, 4-diphenylheptan). Norcodeine (N-demethylcodeine) except when included in Schedule 2 or Schedule 4. Norlevorphanol ((-)-3-hydroxymorphinan). Normethodone ( 6-dimethylamino-4, 4-diphenyl-3-hexanone ). Normorphine (N-demethylated morphine). N orpipanone ( 4, 4-diphenyl-6-piperidine-3-hexanone ). 82 Amendments-The Poisons Regulations of 1973

Opium in any form except the alkaloids noscapine and papaverine. Oxycodone ( 14-hydroxydihydrocodeinone ). Oxymorphone ( 14-hydroxydihydromorphinone). Pentazocine. Pethidine (1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester). Pethidine-Intermediate A (4-cyano-1-methyl-4-phenylpiperidine ). Pethidine-Intermidiate B ( 4-phenylpiperidine-4-carboxylic acid ethyl ester). Pethidine-Intermediate C ( 1-methyl-4-phenylpiperidine-4-carboxylic acid). Phenadoxone (6-morpholino-4, 4-diphenyl-3-heptanone). Phenampromide (N ( 1-methyl-2-piperidinoethyl) propionanilide). Phenazocine (2-hydroxy-5, 9-dimethyl-2'-phenethyl-6, 7-benzomorphan). Phencyclidine. Phenmetrazine. Phenomorphan (3-hydroxy-N-phenethylmorphinan). Phenoperidine ( 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-car­ boxylic acid ethyl ester). 1-(1-Phenylcyclohexyl) pyrrolidine (PHP or PCPY). Pholcodine (morpholinylethyl morphine) except when included in Schedule 4 or Schedule 2. Piminodine (4-phenyl-1-(3-phenylaminopropyl) piperidine-4-carboxylic acid ethyl ester). Piperidine derivatives having addiction properties, not specifically included in this Schedule. Piritramide ( 1-(3-cyano-3 diphenylpropyl)-4-( 1-piperidino) piperidine-4- carboxylic acid amide). Proheptazine ( 1, 3-dimethyl-4-phenyl-4-propionoxyazacyloheptane). Properidine ( 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester). Propiram. Racemethorphan ( ( ± )-methoxy-N-methylmorphinan). Racemoramide ( ( ± )-4-(2-methyl-4-oxo-3, 3-diphenyl-4-( 1-pyrrolidinyl) butyl) morpholine). Racemorphan (( ± )-3-hydroxy-N-methylmorphinan). Sufentanil N -( 4-(methoxymethyl)-1-(2-(2-thienyl)-ethyl-4-piperidyl) propionanilide. Tetrahydrocannabinols. Thebacon (acetyl dihydrocodeinone). Thebaine. Tilidine ( ±) ethyl-trans-2-( dimethylamine )-1-phenyl-3-cyclohexene-1- carboxylate. Amendments-The Poisons Regulations of 1973 83

1-1-(2-Thienyl)cyclohexyl piperidine (TCP). Trimeperidine (1, 2, 5-trimethyl-4-phenyl-4-proprionoxy-piperidine. 27. Schedule 9 of the Principal Regulations is amended by inserting after clause 7 (in Form B) the following clause- "8. Location of place where it is intended to use the strychnine." Given under my hand at Brisbane, this twenty-second day of February, 1985.

P. G. LIVINGSTONE Director-General of Health and Medical Services

66278-By Authority: S. R.HAMPSON, Government Printer, Queensland-1985